"","X","miRNA","V2","V3.x","V4.x","V5","V6","V7","V8","V9","V10","V11","mRNA","PCC.cor","p_value","adjusted_p_value","V3.y","Protein.names","Organism","Gene.Ontology..biological.process.","Gene.Ontology.IDs"
"10",10,"Cluster_10060","Porites_evermani_scaffold_422:57577-58262",167,-21.66,2,21,359,381,20,"75.00%","85.00%","Peve_00029974",0.999736312730338,0.0146200630686234,0.734958779208245,NA,NA,NA,NA,NA
"14",14,"Cluster_10060","Porites_evermani_scaffold_752:6900-7900",166,-20.16,2,21,204,224,19,"73.68%","89.47%","Peve_00040742",-0.999019150266648,0.0281988803309955,0.902129556693968,NA,NA,NA,NA,NA
"62",62,"Cluster_10934","Porites_evermani_scaffold_1556:86789-87789",146,-23.41,2,21,504,521,19,"68.42%","78.95%","Peve_00008185",0.99960187302587,0.0179647150151243,0.782669382293497,NA,NA,NA,NA,NA
"68",68,"Cluster_10934","Porites_evermani_scaffold_165:252591-252781",155,-23.23,2,21,51,75,22,"63.64%","77.27%","Peve_00009398",0.998758250045998,0.0317290557481573,0.903929377050813,NA,NA,NA,NA,NA
"87",87,"Cluster_10934","Porites_evermani_scaffold_2614:64308-65308",162,-21.88,2,20,405,427,19,"73.68%","84.21%","Peve_00019390",0.998758250045999,0.0317290557481559,0.903929377050813,NA,NA,NA,NA,NA
"100",100,"Cluster_10934","Porites_evermani_scaffold_3423:11033-12033",147,-20.08,2,17,882,904,16,"75.00%","75.00%","Peve_00025441",0.999999242056246,0.00078381512101461,0.239778920002343,NA,NA,NA,NA,NA
"101",101,"Cluster_10934","Porites_evermani_scaffold_3423:7309-8309",147,-20.08,2,17,882,904,16,"75.00%","75.00%","Peve_00025440",0.999990991243872,0.00270226453852998,0.439065053827702,NA,NA,NA,NA,NA
"117",117,"Cluster_10934","Porites_evermani_scaffold_724:23743-24743",160,-20.06,2,20,942,961,18,"77.78%","83.33%","Peve_00040130",0.998758250045998,0.0317290557481573,0.903929377050813,NA,NA,NA,NA,NA
"171",171,"Cluster_11134","Porites_evermani_scaffold_1091:4675-5675",162,-25.57,2,21,114,140,24,"70.83%","79.17%","Peve_00001620",0.999331428228842,0.0232805554536455,0.848115847217852,"Q0VD42","TLC domain-containing protein 5 (Transmembrane protein 136)","Bos taurus (Bovine)","","GO:0016020"
"174",174,"Cluster_11134","Porites_evermani_scaffold_111:45436-46436",160,-20.3,2,17,930,951,15,"73.33%","93.33%","Peve_00002001",0.997882460106254,0.0414369314993325,0.909359886114279,NA,NA,NA,NA,NA
"189",189,"Cluster_11134","Porites_evermani_scaffold_128:242650-243650",150,-20.56,2,17,909,929,15,"73.33%","86.67%","Peve_00004498",-0.997520581789295,0.0448393995312029,0.929559323183572,"S8FGV1","Laccase-2 (EC 1.10.3.2) (FpLCC2)","Fomitopsis pinicola (strain FP-58527) (Brown rot fungus)","","GO:0005507; GO:0005576; GO:0016682"
"552",552,"Cluster_11135","Porites_evermani_scaffold_225:51551-52551",162,-23.61,2,20,111,133,19,"73.68%","84.21%","Peve_00016052",0.999263211767585,0.024439545782064,0.861227763182295,"A4FUY7","Molybdopterin synthase catalytic subunit (EC 2.8.1.12) (Molybdenum cofactor synthesis protein 2 large subunit) (Molybdenum cofactor synthesis protein 2B) (MOCS2B)","Bos taurus (Bovine)","Mo-molybdopterin cofactor biosynthetic process [GO:0006777]","GO:0005829; GO:0006777; GO:0016607; GO:0019008; GO:0030366"
"553",553,"Cluster_11135","Porites_evermani_scaffold_2294:26753-27753",170,-20.86,2,21,918,938,19,"78.95%","89.47%","Peve_00016434",0.99900571383746,0.0283914000687859,0.903496866948401,"Q5EBP3","Armadillo repeat-containing protein 5","Mus musculus (Mouse)","adrenal cortex development [GO:0035801]; anatomical structure morphogenesis [GO:0009653]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; defense response to virus [GO:0051607]; gastrulation [GO:0007369]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; mesoderm formation [GO:0001707]; regulation of steroid biosynthetic process [GO:0050810]; T cell proliferation [GO:0042098]","GO:0001701; GO:0001707; GO:0005654; GO:0005737; GO:0005829; GO:0005925; GO:0007369; GO:0009653; GO:0016020; GO:0030097; GO:0035801; GO:0042098; GO:0043367; GO:0050810; GO:0051607"
"561",561,"Cluster_11135","Porites_evermani_scaffold_2787:28268-29268",146,-20.94,2,21,264,290,24,"62.50%","70.83%","Peve_00020772",0.998797404481802,0.0312247122096777,0.903929377050813,NA,NA,NA,NA,NA
"573",573,"Cluster_11135","Porites_evermani_scaffold_32:442334-443334",160,-22.38,2,18,538,560,17,"82.35%","82.35%","Peve_00023991",0.999999420671888,0.000685263252555419,0.239778920002343,"P34152","Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK)","Mus musculus (Mouse)","angiogenesis [GO:0001525]; axonogenesis [GO:0007409]; blood vessel development [GO:0001568]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular chloride ion homeostasis [GO:0030644]; cellular response to transforming growth factor beta stimulus [GO:0071560]; central nervous system neuron axonogenesis [GO:0021955]; endothelial cell migration [GO:0043542]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; extracellular matrix organization [GO:0030198]; growth hormone receptor signaling pathway [GO:0060396]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of organ growth [GO:0046621]; negative regulation of synapse assembly [GO:0051964]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; organ growth [GO:0035265]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of synaptic transmission [GO:0050806]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of wound healing [GO:0090303]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell population proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of osteoblast differentiation [GO:0045667]; regulation of protein phosphorylation [GO:0001932]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; signal complex assembly [GO:0007172]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasculogenesis [GO:0001570]; vasodilation [GO:0042311]","GO:0000165; GO:0000226; GO:0001525; GO:0001568; GO:0001570; GO:0001725; GO:0001764; GO:0001932; GO:0001934; GO:0003779; GO:0004713; GO:0004715; GO:0004725; GO:0005102; GO:0005178; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0005938; GO:0006468; GO:0007097; GO:0007169; GO:0007172; GO:0007173; GO:0007179; GO:0007229; GO:0007254; GO:0007409; GO:0008284; GO:0008360; GO:0008432; GO:0010507; GO:0010613; GO:0010632; GO:0010634; GO:0010718; GO:0010759; GO:0010763; GO:0014068; GO:0014704; GO:0014911; GO:0016323; GO:0016324; GO:0016477; GO:0016604; GO:0018108; GO:0019901; GO:0019902; GO:0019903; GO:0021955; GO:0022408; GO:0030027; GO:0030154; GO:0030155; GO:0030198; GO:0030307; GO:0030335; GO:0030336; GO:0030644; GO:0031234; GO:0033628; GO:0035265; GO:0036064; GO:0038083; GO:0042127; GO:0042169; GO:0042311; GO:0042383; GO:0042802; GO:0043066; GO:0043197; GO:0043231; GO:0043542; GO:0043548; GO:0044877; GO:0045087; GO:0045202; GO:0045667; GO:0045785; GO:0045860; GO:0046621; GO:0046777; GO:0048013; GO:0048471; GO:0048661; GO:0050766; GO:0050771; GO:0050806; GO:0051893; GO:0051897; GO:0051964; GO:0060252; GO:0060396; GO:0071560; GO:0090303; GO:0098794; GO:0098978; GO:0120041; GO:0140677; GO:1900024; GO:1905274; GO:2000060; GO:2000811"
"596",596,"Cluster_11135","Porites_evermani_scaffold_439:231901-232901",151,-22.1,2,21,619,643,22,"63.64%","72.73%","Peve_00030840",0.999931466060162,0.00745333172287407,0.573710369894872,NA,NA,NA,NA,NA
"638",638,"Cluster_1167","Porites_evermani_scaffold_1082:86413-87413",155,-21.98,2,16,285,306,14,"78.57%","85.71%","Peve_00001485",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"639",639,"Cluster_1167","Porites_evermani_scaffold_1087:61454-62454",154,-23.08,2,21,464,484,19,"63.16%","84.21%","Peve_00001544",0.999909726776791,0.00855416971793915,0.573710369894872,"O35474","EGF-like repeat and discoidin I-like domain-containing protein 3 (Developmentally-regulated endothelial cell locus 1 protein) (Integrin-binding protein DEL1)","Mus musculus (Mouse)","cell adhesion [GO:0007155]; positive regulation of cell-substrate adhesion [GO:0010811]","GO:0005509; GO:0005576; GO:0007155; GO:0010811"
"645",645,"Cluster_1167","Porites_evermani_scaffold_1196:15249-16249",150,-21.09,2,21,46,69,21,"66.67%","76.19%","Peve_00003269",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"656",656,"Cluster_1167","Porites_evermani_scaffold_1331:79978-80978",150,-25.11,2,19,455,476,17,"64.71%","76.47%","Peve_00005255",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"658",658,"Cluster_1167","Porites_evermani_scaffold_1342:37224-38224",147,-20.88,2,21,126,148,20,"65.00%","70.00%","Peve_00005406",0.999909726776791,0.00855416971793389,0.573710369894872,NA,NA,NA,NA,NA
"670",670,"Cluster_1167","Porites_evermani_scaffold_1473:2847-3847",156,-22.04,2,18,665,687,17,"76.47%","82.35%","Peve_00007142",0.999909726776791,0.00855416971793389,0.573710369894872,NA,NA,NA,NA,NA
"674",674,"Cluster_1167","Porites_evermani_scaffold_1511:100291-101291",150,-25.62,2,19,312,333,17,"64.71%","76.47%","Peve_00007689",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"691",691,"Cluster_1167","Porites_evermani_scaffold_1720:64731-65731",153,-20.95,2,16,104,124,14,"85.71%","85.71%","Peve_00010286",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"701",701,"Cluster_1167","Porites_evermani_scaffold_2071:77434-78434",159,-23.98,2,21,696,718,20,"75.00%","75.00%","Peve_00014260",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"709",709,"Cluster_1167","Porites_evermani_scaffold_220:245626-246626",152,-23.21,2,13,745,766,11,"90.91%","90.91%","Peve_00015576",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"711",711,"Cluster_1167","Porites_evermani_scaffold_2239:8003-9003",140,-24.8,2,9,385,406,7,"100.00%","100.00%","Peve_00015940",0.998461753312847,0.0353153733346753,0.909359886114279,NA,NA,NA,NA,NA
"713",713,"Cluster_1167","Porites_evermani_scaffold_2295:68739-69739",143,-23.75,2,17,332,359,21,"61.90%","71.43%","Peve_00016445",0.999909726776791,0.00855416971793915,0.573710369894872,"Q9UHC3","Acid-sensing ion channel 3 (ASIC3) (hASIC3) (Amiloride-sensitive cation channel 3) (Neuronal amiloride-sensitive cation channel 3) (Testis sodium channel 1) (hTNaC1)","Homo sapiens (Human)","detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; response to acidic pH [GO:0010447]; response to heat [GO:0009408]; sensory perception [GO:0007600]; sensory perception of sour taste [GO:0050915]; signal transduction [GO:0007165]; sodium ion transmembrane transport [GO:0035725]","GO:0005261; GO:0005272; GO:0005886; GO:0007165; GO:0007600; GO:0009408; GO:0010447; GO:0015280; GO:0035725; GO:0042931; GO:0044736; GO:0048471; GO:0050915; GO:0050965; GO:0050966; GO:0050968"
"717",717,"Cluster_1167","Porites_evermani_scaffold_2414:47059-48059",144,-21.59,2,13,859,880,11,"81.82%","81.82%","Peve_00017626",0.999909726776791,0.00855416971793915,0.573710369894872,"Q7TQP6","Serine/threonine-protein kinase TNNI3K (EC 2.7.11.1) (Cardiac ankyrin repeat kinase) (TNNI3-interacting kinase)","Rattus norvegicus (Rat)","bundle of His cell to Purkinje myocyte communication [GO:0086069]; protein phosphorylation [GO:0006468]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart rate [GO:0002027]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0002027; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006357; GO:0006468; GO:0008022; GO:0031013; GO:0046872; GO:0055117; GO:0061629; GO:0086069; GO:0106310; GO:1903779"
"723",723,"Cluster_1167","Porites_evermani_scaffold_248:239409-240409",151,-24.56,2,19,16,35,17,"76.47%","76.47%","Peve_00018177",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"724",724,"Cluster_1167","Porites_evermani_scaffold_248:239409-240409",151,-24.56,2,19,246,265,17,"76.47%","76.47%","Peve_00018177",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"733",733,"Cluster_1167","Porites_evermani_scaffold_2634:29181-30181",160,-27.23,2,21,579,600,19,"68.42%","78.95%","Peve_00019541",0.998816193083452,0.0309797857569469,0.903929377050813,"O18638","Out at first protein","Drosophila virilis (Fruit fly)","",""
"745",745,"Cluster_1167","Porites_evermani_scaffold_2858:16088-17088",160,-25.15,2,21,389,410,19,"68.42%","78.95%","Peve_00021333",0.999909726776791,0.00855416971793915,0.573710369894872,"Q924H0","Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide NPFF receptor)","Mus musculus (Mouse)","G protein-coupled receptor signaling pathway [GO:0007186]; regulation of adenylate cyclase activity [GO:0045761]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of MAPK cascade [GO:0043408]","GO:0004930; GO:0005886; GO:0007186; GO:0008188; GO:0015629; GO:0031628; GO:0042277; GO:0043408; GO:0045761; GO:2000479"
"746",746,"Cluster_1167","Porites_evermani_scaffold_2858:6867-7867",156,-24.35,2,21,392,413,19,"63.16%","78.95%","Peve_00021330",0.999909726776791,0.00855416971793915,0.573710369894872,"Q924H0","Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide NPFF receptor)","Mus musculus (Mouse)","G protein-coupled receptor signaling pathway [GO:0007186]; regulation of adenylate cyclase activity [GO:0045761]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of MAPK cascade [GO:0043408]","GO:0004930; GO:0005886; GO:0007186; GO:0008188; GO:0015629; GO:0031628; GO:0042277; GO:0043408; GO:0045761; GO:2000479"
"748",748,"Cluster_1167","Porites_evermani_scaffold_290:129145-130145",144,-22.08,2,21,817,838,19,"57.89%","68.42%","Peve_00021718",0.999909726776791,0.00855416971793389,0.573710369894872,NA,NA,NA,NA,NA
"749",749,"Cluster_1167","Porites_evermani_scaffold_290:129145-130145",146,-24.73,2,21,693,718,23,"60.87%","73.91%","Peve_00021718",0.999909726776791,0.00855416971793389,0.573710369894872,NA,NA,NA,NA,NA
"775",775,"Cluster_1167","Porites_evermani_scaffold_3595:33413-34413",147,-23.25,2,21,781,803,20,"65.00%","70.00%","Peve_00026489",0.999909726776791,0.00855416971793389,0.573710369894872,NA,NA,NA,NA,NA
"787",787,"Cluster_1167","Porites_evermani_scaffold_4147:30376-31314",153,-25.03,2,21,120,145,23,"73.91%","73.91%","Peve_00029605",0.999850651123434,0.011002756609976,0.648044327003451,"Q9Y2W6","Tudor and KH domain-containing protein (Tudor domain-containing protein 2)","Homo sapiens (Human)","fertilization [GO:0009566]; male meiotic nuclear division [GO:0007140]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]","GO:0003723; GO:0005739; GO:0007140; GO:0007283; GO:0009566; GO:0030719; GO:0034587; GO:0043186; GO:0071546; GO:0071547"
"788",788,"Cluster_1167","Porites_evermani_scaffold_4157:26015-27015",155,-21.97,2,16,869,890,14,"78.57%","85.71%","Peve_00029642",0.999990221588804,0.00281533203902639,0.450074017033431,NA,NA,NA,NA,NA
"810",810,"Cluster_1167","Porites_evermani_scaffold_5247:3724-4724",146,-22.61,2,13,211,231,11,"90.91%","90.91%","Peve_00034549",0.998849404223647,0.0305420482403264,0.903929377050813,"P49285","Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor) (CKA)","Gallus gallus (Chicken)","adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; circadian rhythm [GO:0007623]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of glucose import [GO:0046325]; negative regulation of glycolytic process [GO:0045820]","GO:0004930; GO:0005886; GO:0007186; GO:0007193; GO:0007623; GO:0008502; GO:0042562; GO:0043235; GO:0045820; GO:0046325; GO:1904408"
"815",815,"Cluster_1167","Porites_evermani_scaffold_540:220328-221328",146,-22.6,2,21,673,697,22,"68.18%","68.18%","Peve_00035161",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"821",821,"Cluster_1167","Porites_evermani_scaffold_590:154196-155196",142,-20.46,2,16,658,680,15,"73.33%","73.33%","Peve_00036721",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"823",823,"Cluster_1167","Porites_evermani_scaffold_590:158279-159279",142,-20.46,2,16,658,680,15,"73.33%","73.33%","Peve_00036723",0.999909726776791,0.00855416971793389,0.573710369894872,NA,NA,NA,NA,NA
"827",827,"Cluster_1167","Porites_evermani_scaffold_61:99144-100144",153,-26.24,2,20,219,242,20,"70.00%","80.00%","Peve_00037343",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"839",839,"Cluster_1167","Porites_evermani_scaffold_742:140467-141467",152,-23.21,2,13,59,80,11,"90.91%","90.91%","Peve_00040549",0.999909726776791,0.00855416971793389,0.573710369894872,NA,NA,NA,NA,NA
"844",844,"Cluster_1167","Porites_evermani_scaffold_792:122223-123223",152,-20.28,2,21,91,112,19,"63.16%","73.68%","Peve_00041552",0.999909726776791,0.00855416971793915,0.573710369894872,NA,NA,NA,NA,NA
"847",847,"Cluster_1167","Porites_evermani_scaffold_818:169331-170331",142,-20.81,2,20,363,386,20,"65.00%","65.00%","Peve_00042134",0.999909726776791,0.00855416971793915,0.573710369894872,"Q91909","Mast/stem cell growth factor receptor-related protein Kit (EC 2.7.10.1) (Kit-related kinase 1) (xKrk1) (Tyrosine-protein kinase kit)","Xenopus laevis (African clawed frog)","Fc receptor signaling pathway [GO:0038093]; Kit signaling pathway [GO:0038109]","GO:0004714; GO:0005524; GO:0005886; GO:0019955; GO:0038093; GO:0038109; GO:0046872"
"848",848,"Cluster_1167","Porites_evermani_scaffold_821:111687-112687",146,-21.74,2,11,153,174,9,"88.89%","100.00%","Peve_00042228",0.999990792524351,0.00273190594675139,0.442041167784887,"Q5R481","Septin-7","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cell division [GO:0051301]; cilium assembly [GO:0060271]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283]","GO:0000776; GO:0005525; GO:0005819; GO:0005930; GO:0007049; GO:0007283; GO:0016476; GO:0030154; GO:0030496; GO:0031105; GO:0031514; GO:0032154; GO:0051301; GO:0060271"
"852",852,"Cluster_1167","Porites_evermani_scaffold_883:47432-48432",149,-21.78,2,14,403,424,12,"83.33%","83.33%","Peve_00043379",0.999909726776791,0.00855416971793389,0.573710369894872,"Q8L7C8","Protein REDUCED WALL ACETYLATION 1 (EC 2.3.1.-)","Arabidopsis thaliana (Mouse-ear cress)","carbohydrate metabolic process [GO:0005975]; plant-type secondary cell wall biogenesis [GO:0009834]; xylan acetylation [GO:1990937]; xylan biosynthetic process [GO:0045492]; xylan metabolic process [GO:0045491]; xyloglucan metabolic process [GO:0010411]","GO:0000139; GO:0005794; GO:0005975; GO:0009834; GO:0010411; GO:0016407; GO:0016491; GO:0045491; GO:0045492; GO:1990937"
"862",862,"Cluster_1167","Porites_evermani_scaffold_99:32693-33542",155,-26.85,2,17,756,778,16,"81.25%","81.25%","Peve_00045222",0.998907226375474,0.0297645814333626,0.903929377050813,NA,NA,NA,NA,NA
"880",880,"Cluster_13502","Porites_evermani_scaffold_1099:147131-148131",159,-22.48,2,18,500,520,16,"75.00%","93.75%","Peve_00001711",0.997844556977271,0.0418062711782376,0.909359886114279,NA,NA,NA,NA,NA
"883",883,"Cluster_13502","Porites_evermani_scaffold_1223:16711-17711",192,-35.54,2,21,283,304,19,"89.47%","100.00%","Peve_00003720",0.997844556977271,0.0418062711782387,0.909359886114279,NA,NA,NA,NA,NA
"892",892,"Cluster_13502","Porites_evermani_scaffold_2209:52957-53957",165,-20.12,2,20,920,943,20,"80.00%","85.00%","Peve_00015657",0.997844556977271,0.0418062711782397,0.909359886114279,"O08730","Glycogenin-1 (GN-1) (GN1) (EC 2.4.1.186)","Rattus norvegicus (Rat)","glycogen biosynthetic process [GO:0005978]","GO:0005536; GO:0005978; GO:0008466; GO:0016757; GO:0030145; GO:0042803; GO:0102751"
"915",915,"Cluster_13502","Porites_evermani_scaffold_504:92338-93338",154,-21.17,2,20,540,562,19,"68.42%","78.95%","Peve_00033788",0.997844556977271,0.0418062711782387,0.909359886114279,NA,NA,NA,NA,NA
"927",927,"Cluster_13502","Porites_evermani_scaffold_899:1146-2146",169,-20.45,2,19,198,220,18,"83.33%","88.89%","Peve_00043584",0.999808930883123,0.0124450682944078,0.68680754891219,NA,NA,NA,NA,NA
"968",968,"Cluster_14999","Porites_evermani_scaffold_110:482487-483487",162,-20.06,2,15,614,635,13,"92.31%","92.31%","Peve_00001876",0.999298315087297,0.0238501759994235,0.854711273077389,"Q6NUE2","Carbonyl reductase family member 4 (EC 1.-.-.-) (3-ketoacyl-[acyl-carrier-protein] reductase beta subunit) (KAR beta subunit) (3-oxoacyl-[acyl-carrier-protein] reductase) (EC 1.1.1.-) (Quinone reductase CBR4)","Xenopus laevis (African clawed frog)","fatty acid biosynthetic process [GO:0006633]; protein heterotetramerization [GO:0051290]","GO:0004316; GO:0005759; GO:0006633; GO:0051290; GO:1990204"
"980",980,"Cluster_14999","Porites_evermani_scaffold_1422:39321-40321",160,-20.25,2,17,644,665,15,"80.00%","86.67%","Peve_00006544",-0.999322492966855,0.0234356254044225,0.849930477652765,"Q9ZQ31","Serine/threonine-protein kinase STY13 (EC 2.7.11.1) (AtSTYPK) (Serine/threonine/tyrosine-protein kinase 13)","Arabidopsis thaliana (Mouse-ear cress)","protein phosphorylation [GO:0006468]; regulation of embryonic development [GO:0045995]; seed oilbody biogenesis [GO:0010344]; signal transduction [GO:0007165]","GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0006468; GO:0007165; GO:0010344; GO:0045995; GO:0106310"
"1016",1016,"Cluster_14999","Porites_evermani_scaffold_2991:42132-43132",157,-21.9,2,19,173,197,20,"75.00%","75.00%","Peve_00022361",0.999976158554056,0.00439604651623863,0.54328949385489,"P98160","Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide]","Homo sapiens (Human)","angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; tissue development [GO:0009888]","GO:0001525; GO:0001540; GO:0005178; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006629; GO:0006898; GO:0006954; GO:0007420; GO:0008022; GO:0009887; GO:0009888; GO:0016525; GO:0030021; GO:0030154; GO:0043202; GO:0050750; GO:0060548; GO:0062023; GO:0070062; GO:0072359; GO:0098797; GO:1905907"
"1049",1049,"Cluster_14999","Porites_evermani_scaffold_560:142359-143359",154,-20.38,2,21,30,58,26,"69.23%","69.23%","Peve_00035813",0.999446977031752,0.0211732108231167,0.821343827072112,NA,NA,NA,NA,NA
"1058",1058,"Cluster_14999","Porites_evermani_scaffold_694:27019-28019",174,-21.61,2,19,50,71,17,"82.35%","94.12%","Peve_00039396",0.998919516701524,0.0295966980402007,0.903929377050813,"Q6DGL2","NF-kappa-B inhibitor-interacting Ras-like protein 2 (I-kappa-B-interacting Ras-like protein 2) (Kappa B-Ras protein 2) (KappaB-Ras2)","Danio rerio (Zebrafish) (Brachydanio rerio)","I-kappaB kinase/NF-kappaB signaling [GO:0007249]; Ral protein signal transduction [GO:0032484]; surfactant homeostasis [GO:0043129]","GO:0003924; GO:0005525; GO:0005737; GO:0007249; GO:0032484; GO:0032794; GO:0043129"
"1067",1067,"Cluster_14999","Porites_evermani_scaffold_844:51243-52243",146,-22.06,2,21,305,333,26,"61.54%","69.23%","Peve_00042650",0.997296425206163,0.0468233205724549,0.939470798087631,"P07850","Sulfite oxidase (EC 1.8.3.1)","Gallus gallus (Chicken)","sulfur compound metabolic process [GO:0006790]","GO:0005739; GO:0005758; GO:0006790; GO:0008482; GO:0020037; GO:0030151; GO:0043546"
"1104",1104,"Cluster_15726","Porites_evermani_scaffold_1823:80909-81909",159,-21.33,2,19,411,430,17,"82.35%","82.35%","Peve_00011436",-0.999947726180961,0.00650937254330571,0.573710369894872,NA,NA,NA,NA,NA
"1108",1108,"Cluster_15726","Porites_evermani_scaffold_1918:41949-42949",147,-20.21,2,21,881,898,19,"68.42%","73.68%","Peve_00012489",1,0,0,NA,NA,NA,NA,NA
"1116",1116,"Cluster_15726","Porites_evermani_scaffold_201:332436-333436",147,-20.04,2,20,688,709,18,"61.11%","72.22%","Peve_00013682",0.999429765887112,0.0215001929584108,0.825175158091499,"B8VIU6","Uncharacterized skeletal organic matrix protein 5 (Uncharacterized SOMP-5)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0005576"
"1126",1126,"Cluster_15726","Porites_evermani_scaffold_2230:31004-32004",160,-23.08,2,21,885,906,19,"73.68%","73.68%","Peve_00015888",1,1.34157585525081e-08,8.89340150118664e-06,"Q9TV36","Fibrillin-1 [Cleaved into: Asprosin]","Sus scrofa (Pig)","activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; protein kinase A signaling [GO:0010737]","GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0008201; GO:0009653; GO:0010737; GO:0031012; GO:0034199; GO:0042593"
"1128",1128,"Cluster_15726","Porites_evermani_scaffold_2256:23302-24302",165,-21.29,2,14,849,870,12,"100.00%","100.00%","Peve_00016106",1,9.48637384723993e-09,6.86838308108347e-06,"Q95LU3","Fibrinogen C domain-containing protein 1","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","","GO:0008061; GO:0016020; GO:0046872"
"1129",1129,"Cluster_15726","Porites_evermani_scaffold_2335:51068-52068",160,-20.05,2,21,302,323,19,"68.42%","78.95%","Peve_00016876",1,1.34157585525081e-08,8.89340150118664e-06,NA,NA,NA,NA,NA
"1142",1142,"Cluster_15726","Porites_evermani_scaffold_2836:49531-50531",160,-24.78,2,21,609,630,19,"73.68%","73.68%","Peve_00021185",-0.999137171835302,0.0264477364816598,0.885091958128636,"Q4R562","Beta-arrestin-1 (Arrestin beta-1)","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0001934; GO:0002092; GO:0005634; GO:0005905; GO:0006511; GO:0007165; GO:0015031; GO:0031143; GO:0031410; GO:0045746"
"1158",1158,"Cluster_15726","Porites_evermani_scaffold_3359:14369-15369",151,-20.82,2,17,399,421,16,"75.00%","81.25%","Peve_00025028",-0.998577868479122,0.0339559968102885,0.909359886114279,NA,NA,NA,NA,NA
"1172",1172,"Cluster_15726","Porites_evermani_scaffold_3974:30779-31779",157,-20.54,2,19,657,680,19,"73.68%","78.95%","Peve_00028583",1,9.48637384723993e-09,6.86838308108347e-06,NA,NA,NA,NA,NA
"1189",1189,"Cluster_15726","Porites_evermani_scaffold_45:429558-430558",158,-22.99,2,21,226,251,23,"69.57%","78.26%","Peve_00031471",-0.999762972739619,0.0138612644080488,0.719823225073345,NA,NA,NA,NA,NA
"1204",1204,"Cluster_15726","Porites_evermani_scaffold_5346:1030-2030",149,-21.02,2,21,71,98,25,"68.00%","72.00%","Peve_00034900",-0.997904126995256,0.0412243184290208,0.909359886114279,NA,NA,NA,NA,NA
"1210",1210,"Cluster_15726","Porites_evermani_scaffold_6242:189-1189",146,-20.27,2,11,800,821,9,"88.89%","100.00%","Peve_00037737",-0.999593925615707,0.0181431468379987,0.782669382293497,"Q3ZCH0","Stress-70 protein, mitochondrial (75 kDa glucose-regulated protein) (GRP-75) (Heat shock 70 kDa protein 9)","Bos taurus (Bovine)","cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; erythrocyte differentiation [GO:0030218]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hemopoiesis [GO:1903707]; protein export from nucleus [GO:0006611]; protein refolding [GO:0042026]; regulation of erythrocyte differentiation [GO:0045646]","GO:0005524; GO:0005730; GO:0005737; GO:0005739; GO:0006611; GO:0016226; GO:0016887; GO:0030218; GO:0031072; GO:0031625; GO:0034620; GO:0042026; GO:0042645; GO:0044183; GO:0045646; GO:0045647; GO:0051082; GO:0051085; GO:0051787; GO:0140662; GO:1902037; GO:1903707"
"1228",1228,"Cluster_15726","Porites_evermani_scaffold_986:47990-48990",158,-20.18,2,19,287,308,17,"70.59%","82.35%","Peve_00045142",1,1.34157585525081e-08,8.89340150118664e-06,"O54991","Contactin-associated protein 1 (Caspr) (Caspr1) (MHDNIV) (NCP1) (Neurexin IV) (Neurexin-4) (Paranodin)","Mus musculus (Mouse)","axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; regulation of synapse maturation [GO:0090128]","GO:0002175; GO:0005886; GO:0005918; GO:0007005; GO:0007010; GO:0007155; GO:0007409; GO:0016020; GO:0017124; GO:0019227; GO:0022010; GO:0022011; GO:0030424; GO:0030913; GO:0031175; GO:0033010; GO:0033270; GO:0042552; GO:0043209; GO:0048786; GO:0048812; GO:0050884; GO:0050885; GO:0050905; GO:0071205; GO:0090128; GO:0097106; GO:0098529; GO:0098978; GO:1990227"
"1235",1235,"Cluster_15890","Porites_evermani_scaffold_1548:71038-72038",176,-20.71,2,21,307,328,19,"78.95%","89.47%","Peve_00008072",-0.998282282435782,0.0373192738625068,0.909359886114279,NA,NA,NA,NA,NA
"1282",1282,"Cluster_16738","Porites_evermani_scaffold_1522:115932-116932",161,-20.31,2,14,320,341,12,"91.67%","100.00%","Peve_00007806",0.999974190676381,0.00457387578917121,0.54328949385489,NA,NA,NA,NA,NA
"1432",1432,"Cluster_2787","Porites_evermani_scaffold_207:73123-74123",154,-21.98,2,21,447,467,19,"68.42%","78.95%","Peve_00014228",0.997036573432838,0.0490229581666764,0.949574829383869,NA,NA,NA,NA,NA
"1433",1433,"Cluster_2787","Porites_evermani_scaffold_207:73123-74123",161,-20.26,2,19,825,847,18,"77.78%","83.33%","Peve_00014228",0.997036573432838,0.0490229581666764,0.949574829383869,NA,NA,NA,NA,NA
"1479",1479,"Cluster_2787","Porites_evermani_scaffold_2655:58204-59204",163,-21.71,2,21,199,221,20,"75.00%","80.00%","Peve_00019695",0.998742428996946,0.0319305869438654,0.905632568744263,"Q91YK2","Ribosomal RNA processing protein 1 homolog B (RRP1-like protein B)","Mus musculus (Mouse)","apoptotic process [GO:0006915]; cellular response to virus [GO:0098586]; mRNA processing [GO:0006397]; negative regulation of GTPase activity [GO:0034260]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364]","GO:0000791; GO:0000792; GO:0001652; GO:0003713; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006364; GO:0006397; GO:0006915; GO:0008380; GO:0030687; GO:0030688; GO:0034260; GO:0043065; GO:0043484; GO:0043923; GO:0045944; GO:0098586"
"1509",1509,"Cluster_2787","Porites_evermani_scaffold_319:203593-204593",148,-21,2,20,696,720,22,"68.18%","72.73%","Peve_00023931",0.997268981044785,0.0470604815083167,0.940685113548625,"P50549","ETS translocation variant 1 (Ets-related protein 81)","Homo sapiens (Human)","axon guidance [GO:0007411]; cell differentiation [GO:0030154]; mechanosensory behavior [GO:0007638]; muscle organ development [GO:0007517]; peripheral nervous system neuron development [GO:0048935]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]","GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0006366; GO:0007411; GO:0007517; GO:0007638; GO:0030154; GO:0045944; GO:0048935; GO:1990837"
"1518",1518,"Cluster_2787","Porites_evermani_scaffold_337:73551-74551",152,-21.52,2,21,585,604,19,"73.68%","78.95%","Peve_00025086",-0.999963153550721,0.00546505171493988,0.551398425649056,NA,NA,NA,NA,NA
"1586",1586,"Cluster_2787","Porites_evermani_scaffold_57:312852-313852",158,-23.01,2,21,595,615,19,"73.68%","78.95%","Peve_00036122",0.998020559760609,0.0400624940598234,0.909359886114279,NA,NA,NA,NA,NA
"1593",1593,"Cluster_2787","Porites_evermani_scaffold_60:343976-344976",150,-21.21,2,21,349,373,22,"68.18%","72.73%","Peve_00037061",-0.999649545771953,0.0168547943103946,0.778328904052462,"Q92820","Gamma-glutamyl hydrolase (EC 3.4.19.9) (Conjugase) (GH) (Gamma-Glu-X carboxypeptidase)","Homo sapiens (Human)","tetrahydrofolylpolyglutamate metabolic process [GO:0046900]","GO:0005576; GO:0005615; GO:0005634; GO:0005773; GO:0008238; GO:0008242; GO:0034722; GO:0035578; GO:0035580; GO:0042470; GO:0046900; GO:0070062; GO:1904724"
"1601",1601,"Cluster_2787","Porites_evermani_scaffold_682:92964-93879",158,-21.8,2,21,666,691,23,"69.57%","78.26%","Peve_00039122",0.997623736355649,0.0438963560597039,0.922643131738102,"Q9BYE2","Transmembrane protease serine 13 (EC 3.4.21.-) (Membrane-type mosaic serine protease) (Mosaic serine protease)","Homo sapiens (Human)","proteolysis [GO:0006508]","GO:0004252; GO:0005044; GO:0006508; GO:0016020; GO:0072562"
"1613",1613,"Cluster_2787","Porites_evermani_scaffold_82:578818-579818",152,-21.18,2,21,347,368,19,"68.42%","68.42%","Peve_00042177",0.999318127749319,0.0235110112931456,0.850665296699579,"Q96LK0","Centrosomal protein of 19 kDa (Cep19)","Homo sapiens (Human)","cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; vesicle targeting, trans-Golgi to periciliary membrane compartment [GO:0097712]","GO:0000922; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005929; GO:0034454; GO:0036064; GO:0060271; GO:0097712"
"1631",1631,"Cluster_2854","Porites_evermani_scaffold_101:86928-87928",148,-20.88,2,14,173,196,14,"78.57%","85.71%","Peve_00000377",0.997896558563532,0.0412987102322654,0.909359886114279,"Q55DA0","ABC transporter G family member 22 (ABC transporter ABCG.22)","Dictyostelium discoideum (Social amoeba)","aggregation involved in sorocarp development [GO:0031152]; cell motility [GO:0048870]; sorocarp morphogenesis [GO:0031288]; transmembrane transport [GO:0055085]","GO:0005524; GO:0016020; GO:0016887; GO:0031152; GO:0031288; GO:0042626; GO:0048870; GO:0055085; GO:0140359"
"1634",1634,"Cluster_2854","Porites_evermani_scaffold_1069:139502-140502",159,-21.31,2,20,162,183,18,"72.22%","77.78%","Peve_00001268",0.999962448044095,0.00551712420276981,0.551398425649056,NA,NA,NA,NA,NA
"1654",1654,"Cluster_2854","Porites_evermani_scaffold_1274:58721-59721",160,-20.55,2,19,748,771,19,"78.95%","84.21%","Peve_00004417",0.998804655877086,0.031130411862649,0.903929377050813,NA,NA,NA,NA,NA
"1681",1681,"Cluster_2854","Porites_evermani_scaffold_1791:63755-64755",146,-20.55,2,21,100,126,24,"66.67%","66.67%","Peve_00011018",-0.999898831254468,0.00905569870901151,0.591707940755134,NA,NA,NA,NA,NA
"1685",1685,"Cluster_2854","Porites_evermani_scaffold_18:431398-432398",153,-21.61,2,14,478,499,12,"83.33%","91.67%","Peve_00011155",0.999983740199231,0.00363039030884399,0.527140119669662,NA,NA,NA,NA,NA
"1689",1689,"Cluster_2854","Porites_evermani_scaffold_2040:84488-85488",166,-20.5,2,21,65,85,19,"73.68%","89.47%","Peve_00013972",0.999962448044095,0.00551712420276981,0.551398425649056,"Q9VBW3","Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)","Drosophila melanogaster (Fruit fly)","calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]","GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0014068; GO:0016339; GO:0033674; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0090303"
"1709",1709,"Cluster_2854","Porites_evermani_scaffold_2548:41242-42242",163,-21.24,2,21,889,912,21,"76.19%","76.19%","Peve_00018828",0.998059288344699,0.0396685101306057,0.909359886114279,NA,NA,NA,NA,NA
"1719",1719,"Cluster_2854","Porites_evermani_scaffold_3060:27010-28010",167,-20.56,2,20,420,441,18,"77.78%","83.33%","Peve_00023071",0.999962448044095,0.00551712420276166,0.551398425649056,NA,NA,NA,NA,NA
"1731",1731,"Cluster_2854","Porites_evermani_scaffold_33:436056-437056",159,-20.29,2,20,562,583,18,"61.11%","88.89%","Peve_00024587",-0.997501684128481,0.0450100248602691,0.930633997430282,"Q9VCA2","Organic cation transporter protein","Drosophila melanogaster (Fruit fly)","apoptotic process [GO:0006915]; ion transport [GO:0006811]","GO:0006811; GO:0006915; GO:0016020; GO:0022857"
"1773",1773,"Cluster_2854","Porites_evermani_scaffold_546:130408-131408",150,-20.22,2,15,853,874,13,"76.92%","84.62%","Peve_00035329",0.998029698096393,0.0399698798387951,0.909359886114279,NA,NA,NA,NA,NA
"1793",1793,"Cluster_2854","Porites_evermani_scaffold_6869:3658-3892",149,-22.41,2,21,76,98,21,"66.67%","76.19%","Peve_00039198",-0.997118363096831,0.0483413856135186,0.946447951505117,"O75897","Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.1) (Sulfotransferase 1C2) (SULT1C#2)","Homo sapiens (Human)","3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; doxorubicin metabolic process [GO:0044598]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; sulfation [GO:0051923]; xenobiotic metabolic process [GO:0006805]","GO:0004062; GO:0005737; GO:0005829; GO:0006068; GO:0006805; GO:0008146; GO:0009812; GO:0044598; GO:0050427; GO:0051923"
"1847",1847,"Cluster_2882","Porites_evermani_scaffold_1735:0-787",147,-21.44,2,21,121,147,24,"62.50%","66.67%","Peve_00010433",-0.99813899500858,0.0388451018771475,0.909359886114279,"Q6NSI8","SANT and BTB domain regulator of class switch recombination (SANT and BTB domain regulator of CSR)","Homo sapiens (Human)","isotype switching [GO:0045190]","GO:0042802; GO:0045190"
"1854",1854,"Cluster_2882","Porites_evermani_scaffold_1890:93851-94851",169,-23.55,2,19,372,395,19,"78.95%","89.47%","Peve_00012142",-0.997089131731783,0.0485860732748588,0.947668828184205,"Q12834","Cell division cycle protein 20 homolog (p55CDC)","Homo sapiens (Human)","anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell differentiation [GO:0030154]; cell division [GO:0051301]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; nervous system development [GO:0007399]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein ubiquitination [GO:0016567]; regulation of dendrite development [GO:0050773]; regulation of meiotic cell cycle [GO:0051445]; regulation of meiotic nuclear division [GO:0040020]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005654; GO:0005680; GO:0005813; GO:0005819; GO:0005829; GO:0007064; GO:0007094; GO:0007346; GO:0007399; GO:0008022; GO:0008284; GO:0010997; GO:0016567; GO:0019899; GO:0030154; GO:0031145; GO:0031915; GO:0033597; GO:0040020; GO:0042826; GO:0048471; GO:0050773; GO:0051301; GO:0051444; GO:0051445; GO:0090129; GO:0090307; GO:1904668; GO:1905786; GO:1990757"
"1888",1888,"Cluster_2882","Porites_evermani_scaffold_310:30150-31150",162,-24.47,2,15,257,278,13,"84.62%","100.00%","Peve_00023391",-0.999656503413255,0.0166866349892639,0.775337211553618,"Q1PSW8","E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (mLin41) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71)","Mus musculus (Mouse)","3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to organic substance [GO:0071310]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA metabolic process [GO:0010586]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; post-transcriptional regulation of gene expression [GO:0010608]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of protein metabolic process [GO:0051246]; stem cell proliferation [GO:0072089]","GO:0000082; GO:0000209; GO:0000932; GO:0001843; GO:0004842; GO:0008270; GO:0008543; GO:0010586; GO:0010608; GO:0017148; GO:0021915; GO:0030371; GO:0035196; GO:0035198; GO:0035278; GO:0043161; GO:0051246; GO:0051865; GO:0060964; GO:0061158; GO:0061630; GO:0071310; GO:0072089; GO:2000177; GO:2000637"
"1906",1906,"Cluster_2882","Porites_evermani_scaffold_45:5053-6053",166,-22.51,2,21,763,788,23,"73.91%","82.61%","Peve_00031436",-0.998016621951657,0.0401023366876437,0.909359886114279,"Q0P5B1","Peroxisomal membrane protein PEX13 (Peroxin-13)","Bos taurus (Bovine)","cerebral cortex cell migration [GO:0021795]; fatty acid alpha-oxidation [GO:0001561]; locomotory behavior [GO:0007626]; microtubule-based peroxisome localization [GO:0060152]; neuron migration [GO:0001764]; protein import into peroxisome matrix, docking [GO:0016560]; suckling behavior [GO:0001967]","GO:0001561; GO:0001764; GO:0001967; GO:0005778; GO:0007626; GO:0008320; GO:0016560; GO:0021795; GO:0060152; GO:1990429"
"1952",1952,"Cluster_29","Porites_evermani_scaffold_2014:26035-27035",155,-20.25,2,20,449,467,18,"72.22%","83.33%","Peve_00013718",0.999652457614836,0.0167846228939752,0.776954707475336,NA,NA,NA,NA,NA
"1960",1960,"Cluster_29","Porites_evermani_scaffold_27:867342-868342",159,-20.95,2,21,842,864,20,"65.00%","85.00%","Peve_00020075",-0.99757215116682,0.0443704514965721,0.926335665692565,NA,NA,NA,NA,NA
"2021",2021,"Cluster_4079","Porites_evermani_scaffold_2:1132302-1133302",156,-20.02,2,21,84,105,19,"63.16%","78.95%","Peve_00013396",-0.999820977218369,0.0120463575804017,0.676535186799302,"Q925Q3","Mitochondrial sodium/calcium exchanger protein (Na(+)/K(+)/Ca(2+)-exchange protein 6) (Sodium/calcium exchanger protein, mitochondrial) (Sodium/potassium/calcium exchanger 6) (Solute carrier family 24 member 6) (Solute carrier family 8 member B1)","Mus musculus (Mouse)","calcium export from the mitochondrion [GO:0099093]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874]; glucose homeostasis [GO:0042593]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of insulin secretion [GO:0050796]; regulation of lymphocyte chemotaxis [GO:1901623]; regulation of store-operated calcium entry [GO:2001256]; response to stimulus [GO:0050896]; sodium ion transmembrane transport [GO:0035725]","GO:0005432; GO:0005739; GO:0005743; GO:0005886; GO:0006812; GO:0006851; GO:0006874; GO:0008324; GO:0016020; GO:0030061; GO:0031966; GO:0035725; GO:0042383; GO:0042593; GO:0042802; GO:0042803; GO:0050796; GO:0050896; GO:0051480; GO:0051560; GO:0070588; GO:0086036; GO:0086038; GO:0099093; GO:1901623; GO:2001256"
"2028",2028,"Cluster_4079","Porites_evermani_scaffold_2219:68259-69259",171,-21.11,2,20,653,674,18,"83.33%","83.33%","Peve_00015748",-0.999044377811527,0.0278338206502373,0.899469696283718,"P0CI65","Nephrocystin-3","Danio rerio (Zebrafish) (Brachydanio rerio)","cilium assembly [GO:0060271]; convergent extension [GO:0060026]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; left/right pattern formation [GO:0060972]; pronephros development [GO:0048793]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]","GO:0001822; GO:0003146; GO:0005929; GO:0007368; GO:0007601; GO:0016055; GO:0048793; GO:0060026; GO:0060271; GO:0060972; GO:0070121; GO:0097543; GO:0097546"
"2045",2045,"Cluster_4079","Porites_evermani_scaffold_3021:53225-54225",154,-21.51,2,20,62,85,20,"60.00%","85.00%","Peve_00022789",0.999909031516669,0.0085870479919059,0.575101679046124,NA,NA,NA,NA,NA
"2085",2085,"Cluster_4079","Porites_evermani_scaffold_541:193793-194793",158,-20.23,2,20,417,439,19,"68.42%","84.21%","Peve_00035192",-0.998775289031826,0.03151056991983,0.903929377050813,"Q80XJ3","Tetratricopeptide repeat protein 28 (TPR repeat protein 28)","Mus musculus (Mouse)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0005737; GO:0005813; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301; GO:0072686; GO:0097431; GO:1990023"
"2094",2094,"Cluster_4079","Porites_evermani_scaffold_636:90422-91422",146,-20.12,2,20,13,35,19,"63.16%","73.68%","Peve_00038009",-0.999936297068816,0.00718583323943983,0.573710369894872,"P15178","Aspartate--tRNA ligase, cytoplasmic (EC 6.1.1.12) (Aspartyl-tRNA synthetase) (AspRS)","Rattus norvegicus (Rat)","aspartyl-tRNA aminoacylation [GO:0006422]","GO:0003723; GO:0004815; GO:0005524; GO:0005737; GO:0005829; GO:0006422; GO:0017101; GO:0045202"
"2129",2129,"Cluster_4080","Porites_evermani_scaffold_1461:30812-31812",165,-20.75,2,20,758,781,20,"75.00%","90.00%","Peve_00006985",-0.998052429938545,0.0397385645947719,0.909359886114279,"Q9H4G4","Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2)","Homo sapiens (Human)","positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]","GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0042803; GO:0070062; GO:0070374"
"2143",2143,"Cluster_4080","Porites_evermani_scaffold_185:171141-172141",161,-21.13,2,21,615,638,22,"77.27%","77.27%","Peve_00011705",0.998232761629708,0.037853554466726,0.909359886114279,NA,NA,NA,NA,NA
"2149",2149,"Cluster_4080","Porites_evermani_scaffold_1978:17170-17866",162,-20.91,2,15,566,587,13,"84.62%","100.00%","Peve_00013087",-0.999999672229045,0.000515442667547547,0.239778920002343,"Q7TN88","Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)","Mus musculus (Mouse)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"2221",2221,"Cluster_4080","Porites_evermani_scaffold_563:175532-176532",161,-20.29,2,21,329,350,20,"75.00%","85.00%","Peve_00035886",-0.999981340367671,0.00388908412218857,0.54328949385489,"Q6DE14","Transcription factor E2F4 (E2F-4)","Xenopus laevis (African clawed frog)","centriole assembly [GO:0098534]; motile cilium assembly [GO:0044458]; multi-ciliated epithelial cell differentiation [GO:1903251]; positive regulation of transcription by RNA polymerase II [GO:0045944]","GO:0000978; GO:0003700; GO:0005634; GO:0005667; GO:0044458; GO:0045944; GO:0046983; GO:0098534; GO:1903251"
"2228",2228,"Cluster_4080","Porites_evermani_scaffold_623:104387-105387",172,-21.91,2,19,957,977,17,"88.24%","94.12%","Peve_00037697",-0.999168966643069,0.0259558006313078,0.879507868160642,"O62742","Sterol carrier protein 2 (SCP-2) (Acetyl-CoA C-myristoyltransferase) (EC 2.3.1.155) (Non-specific lipid-transfer protein) (NSL-TP) (Propanoyl-CoA C-acyltransferase) (EC 2.3.1.176) (SCP-2/3-oxoacyl-CoA thiolase) (SCP-2/thiolase) (EC 2.3.1.16) (SCP-chi) (SCPX) (Sterol carrier protein X) (SCP-X)","Oryctolagus cuniculus (Rabbit)","bile acid metabolic process [GO:0008206]; fatty acid beta-oxidation [GO:0006635]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; regulation of phospholipid biosynthetic process [GO:0071071]","GO:0003988; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005783; GO:0006635; GO:0006869; GO:0008206; GO:0008289; GO:0032367; GO:0033814; GO:0050632; GO:0050633; GO:0071071; GO:0120019; GO:0120020"
"2231",2231,"Cluster_4080","Porites_evermani_scaffold_6:665825-666825",167,-21.47,2,20,777,798,18,"77.78%","83.33%","Peve_00036963",0.999351594621176,0.0229267182870592,0.843538272975541,"Q8WU76","Sec1 family domain-containing protein 2 (Syntaxin-binding protein 1-like 1)","Homo sapiens (Human)","intracellular protein transport [GO:0006886]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192]","GO:0005886; GO:0006886; GO:0006904; GO:0016192; GO:0019905; GO:0030141"
"2244",2244,"Cluster_4080","Porites_evermani_scaffold_893:112442-113442",161,-20.29,2,18,577,598,16,"75.00%","87.50%","Peve_00043526",0.998465344822469,0.0352741113828147,0.909359886114279,NA,NA,NA,NA,NA
"2329",2329,"Cluster_4629","Porites_evermani_scaffold_1071:25544-26544",150,-20.45,2,21,296,316,19,"68.42%","73.68%","Peve_00001326",-0.997041811903654,0.0489795884758296,0.949444666171571,"Q505F5","Leucine-rich repeat-containing protein 47","Mus musculus (Mouse)","phenylalanyl-tRNA aminoacylation [GO:0006432]","GO:0003723; GO:0004826; GO:0006432"
"2334",2334,"Cluster_4629","Porites_evermani_scaffold_1137:25604-26604",140,-21.96,2,9,1,17,7,"100.00%","100.00%","Peve_00002365",0.997938030915672,0.0408894104551393,0.909359886114279,NA,NA,NA,NA,NA
"2335",2335,"Cluster_4629","Porites_evermani_scaffold_1144:119483-120483",161,-23.63,2,21,861,885,22,"77.27%","81.82%","Peve_00002477",0.997938030915672,0.0408894104551393,0.909359886114279,NA,NA,NA,NA,NA
"2352",2352,"Cluster_4629","Porites_evermani_scaffold_1347:20083-21083",172,-30.34,2,21,633,654,19,"73.68%","89.47%","Peve_00005452",0.997938030915672,0.0408894104551393,0.909359886114279,"Q9FGB1",NA,NA,NA,NA
"2378",2378,"Cluster_4629","Porites_evermani_scaffold_1686:37355-38355",161,-21.15,2,18,183,204,16,"75.00%","87.50%","Peve_00009813",0.997938030915672,0.0408894104551393,0.909359886114279,NA,NA,NA,NA,NA
"2427",2427,"Cluster_4629","Porites_evermani_scaffold_2202:2874-3874",147,-22.68,2,21,251,276,23,"60.87%","69.57%","Peve_00015601",0.997938030915672,0.0408894104551393,0.909359886114279,NA,NA,NA,NA,NA
"2455",2455,"Cluster_4629","Porites_evermani_scaffold_2680:12440-13440",152,-22.41,2,21,816,837,19,"57.89%","78.95%","Peve_00019915",0.997938030915672,0.0408894104551393,0.909359886114279,NA,NA,NA,NA,NA
"2490",2490,"Cluster_4629","Porites_evermani_scaffold_3271:25359-26359",146,-20.47,2,19,197,215,17,"70.59%","76.47%","Peve_00024444",-0.999839766742431,0.0113966510517457,0.658396521887265,"Q9QYP0","Multiple epidermal growth factor-like domains protein 8 (Multiple EGF-like domains protein 8) (Epidermal growth factor-like protein 4) (EGF-like protein 4)","Rattus norvegicus (Rat)","animal organ morphogenesis [GO:0009887]; BMP signaling pathway [GO:0030509]; cell migration involved in gastrulation [GO:0042074]; coronary vasculature development [GO:0060976]; craniofacial suture morphogenesis [GO:0097094]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; epiboly involved in gastrulation with mouth forming second [GO:0055113]; fasciculation of sensory neuron axon [GO:0097155]; left/right pattern formation [GO:0060972]; limb morphogenesis [GO:0035108]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of axon extension involved in axon guidance [GO:0048842]; regulation of gene expression [GO:0010468]; tissue development [GO:0009888]","GO:0003143; GO:0005509; GO:0005634; GO:0007368; GO:0009887; GO:0009888; GO:0010468; GO:0016020; GO:0030326; GO:0030509; GO:0035108; GO:0042074; GO:0045879; GO:0048704; GO:0048842; GO:0055113; GO:0060971; GO:0060972; GO:0060976; GO:0061371; GO:0071907; GO:0097094; GO:0097155"
"2511",2511,"Cluster_4629","Porites_evermani_scaffold_3741:9939-10939",167,-25.95,2,21,449,472,21,"71.43%","85.71%","Peve_00027295",-0.998044922586829,0.0398151065215797,0.909359886114279,"Q9NTJ4","Alpha-mannosidase 2C1 (EC 3.2.1.24) (Alpha mannosidase 6A8B) (Alpha-D-mannoside mannohydrolase) (Mannosidase alpha class 2C member 1)","Homo sapiens (Human)","mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]","GO:0004559; GO:0005654; GO:0005829; GO:0006013; GO:0009313; GO:0030246; GO:0046872"
"2533",2533,"Cluster_4629","Porites_evermani_scaffold_4334:3468-4468",158,-24.39,2,20,967,989,19,"68.42%","84.21%","Peve_00030606",0.99730289693183,0.0467672197087773,0.939470798087631,"Q9VCA2","Organic cation transporter protein","Drosophila melanogaster (Fruit fly)","apoptotic process [GO:0006915]; ion transport [GO:0006811]","GO:0006811; GO:0006915; GO:0016020; GO:0022857"
"2567",2567,"Cluster_4629","Porites_evermani_scaffold_547:85919-86919",162,-24.89,2,20,50,72,19,"78.95%","78.95%","Peve_00035367",0.997938030915672,0.0408894104551393,0.909359886114279,NA,NA,NA,NA,NA
"2587",2587,"Cluster_4629","Porites_evermani_scaffold_593:15876-16876",162,-24.92,2,21,572,597,23,"73.91%","78.26%","Peve_00036785",0.997938030915672,0.0408894104551393,0.909359886114279,"Q17LW0","Myosin-VIIa (Protein crinkled)","Aedes aegypti (Yellowfever mosquito) (Culex aegypti)","actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605]","GO:0000146; GO:0003779; GO:0005524; GO:0005737; GO:0007605; GO:0008407; GO:0016459; GO:0030048; GO:0032027; GO:0035317; GO:0048800; GO:0071944; GO:0120025"
"2599",2599,"Cluster_4629","Porites_evermani_scaffold_6:466025-467025",164,-26.7,2,21,765,786,19,"73.68%","78.95%","Peve_00036947",0.99868990037373,0.0325907764753561,0.909359886114279,NA,NA,NA,NA,NA
"2631",2631,"Cluster_4629","Porites_evermani_scaffold_819:70668-71668",157,-24.55,2,14,624,645,12,"91.67%","91.67%","Peve_00042151",0.997938030915672,0.0408894104551393,0.909359886114279,NA,NA,NA,NA,NA
"2633",2633,"Cluster_4629","Porites_evermani_scaffold_832:137129-138129",157,-21.66,2,21,660,679,19,"73.68%","78.95%","Peve_00042435",0.997262417278732,0.0471170262500777,0.94113497813925,NA,NA,NA,NA,NA
"2642",2642,"Cluster_4629","Porites_evermani_scaffold_900:13228-14228",146,-20.9,2,20,932,955,20,"60.00%","75.00%","Peve_00043768",0.997938030915673,0.0408894104551382,0.909359886114279,NA,NA,NA,NA,NA
"2658",2658,"Cluster_4629","Porites_evermani_scaffold_9:533373-534373",152,-21.26,2,19,146,170,20,"70.00%","80.00%","Peve_00043615",0.999186729228898,0.0256768734393112,0.876415971818516,"P55006","Retinol dehydrogenase 7 (EC 1.1.1.105) (Retinol dehydrogenase 3) (Retinol dehydrogenase type III) (RODH III)","Rattus norvegicus (Rat)","retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]","GO:0004745; GO:0005783; GO:0008202; GO:0016491; GO:0042572; GO:0043231"
"2679",2679,"Cluster_4735","Porites_evermani_scaffold_13:783653-784653",165,-23.35,2,20,440,460,18,"83.33%","83.33%","Peve_00004731",-0.999783900702665,0.0132351729066914,0.705702184467113,"Q6DEW6","RNA exonuclease 4 (EC 3.1.-.-) (Exonuclease XPMC2) (Prevents mitotic catastrophe 2 protein)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","rRNA processing [GO:0006364]","GO:0003676; GO:0005634; GO:0006364; GO:0008408"
"2684",2684,"Cluster_4735","Porites_evermani_scaffold_14:57292-58292",163,-22.3,2,20,64,85,18,"72.22%","83.33%","Peve_00006174",-0.998701518193497,0.032445917538854,0.909359886114279,NA,NA,NA,NA,NA
"2738",2738,"Cluster_4735","Porites_evermani_scaffold_336:194729-195729",151,-20.32,2,21,710,727,19,"73.68%","73.68%","Peve_00025044",-0.999885283611896,0.00964299640621119,0.610514562090407,"Q04073","DNA-binding protein P3A2","Strongylocentrotus purpuratus (Purple sea urchin)","regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357"
"2756",2756,"Cluster_4735","Porites_evermani_scaffold_4939:12948-13948",147,-20.12,2,12,895,916,10,"90.00%","90.00%","Peve_00033287",-0.998878569589875,0.0301523995600735,0.903929377050813,"Q9R1L5","Microtubule-associated serine/threonine-protein kinase 1 (EC 2.7.11.1) (Syntrophin-associated serine/threonine-protein kinase)","Mus musculus (Mouse)","brain development [GO:0007420]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]","GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005856; GO:0005886; GO:0006468; GO:0007010; GO:0007420; GO:0008017; GO:0016020; GO:0018105; GO:0030424; GO:0030425; GO:0035556; GO:0043005; GO:0043025; GO:0106310"
"2758",2758,"Cluster_4735","Porites_evermani_scaffold_510:219735-220735",148,-20.37,2,20,547,571,22,"63.64%","77.27%","Peve_00034069",0.99999940598563,0.000693894776259953,0.239778920002343,NA,NA,NA,NA,NA
"2759",2759,"Cluster_4735","Porites_evermani_scaffold_514:140247-140920",159,-25.02,2,16,457,478,14,"78.57%","92.86%","Peve_00034189",-0.999325369433971,0.0233858169858483,0.84919156053953,"Q6P3D0","U8 snoRNA-decapping enzyme (EC 3.6.1.62) (IDP phosphatase) (IDPase) (EC 3.6.1.64) (Inosine diphosphate phosphatase) (Nucleoside diphosphate-linked moiety X motif 16) (Nudix motif 16) (m7GpppN-mRNA hydrolase)","Mus musculus (Mouse)","chromosome organization [GO:0051276]; dITP catabolic process [GO:0035863]; mRNA catabolic process [GO:0006402]; NAD-cap decapping [GO:0110155]; negative regulation of rRNA processing [GO:2000233]; positive regulation of cell cycle process [GO:0090068]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; sno(s)RNA catabolic process [GO:0016077]","GO:0000166; GO:0000287; GO:0003729; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006402; GO:0008235; GO:0016077; GO:0030145; GO:0030515; GO:0031404; GO:0035863; GO:0035870; GO:0042802; GO:0042803; GO:0050072; GO:0050897; GO:0051276; GO:0090068; GO:0090502; GO:0097383; GO:0110152; GO:0110155; GO:0140933; GO:1990003; GO:1990174; GO:2000233"
"2762",2762,"Cluster_4735","Porites_evermani_scaffold_543:180249-181249",156,-21.28,2,21,707,728,19,"63.16%","78.95%","Peve_00035232",0.99999940598563,0.000693894776195108,0.239778920002343,NA,NA,NA,NA,NA
"2792",2792,"Cluster_4735","Porites_evermani_scaffold_838:73392-74392",150,-21.28,2,19,563,584,17,"64.71%","76.47%","Peve_00042498",0.999891079350943,0.00939624156020117,0.602954859488328,NA,NA,NA,NA,NA
"2972",2972,"Cluster_5882","Porites_evermani_scaffold_5754:1822-2822",167,-20.17,2,21,518,540,20,"75.00%","85.00%","Peve_00036264",0.997786572068102,0.0423650724088565,0.91271866035762,NA,NA,NA,NA,NA
"3046",3046,"Cluster_589","Porites_evermani_scaffold_157:272383-273383",155,-20.03,2,21,84,106,20,"70.00%","75.00%","Peve_00008377",-0.999957293079344,0.00588363598502496,0.570680688799154,NA,NA,NA,NA,NA
"3051",3051,"Cluster_589","Porites_evermani_scaffold_1654:21847-22847",160,-23.47,2,19,629,649,17,"76.47%","88.24%","Peve_00009458",-0.998175220682579,0.0384650550931703,0.909359886114279,"Q14674","Separin (EC 3.4.22.49) (Caspase-like protein ESPL1) (Extra spindle poles-like 1 protein) (Separase)","Homo sapiens (Human)","apoptotic process [GO:0006915]; establishment of mitotic spindle localization [GO:0040001]; homologous chromosome segregation [GO:0045143]; meiotic chromosome separation [GO:0051307]; meiotic spindle organization [GO:0000212]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of sister chromatid cohesion [GO:0045875]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; proteolysis [GO:0006508]","GO:0000070; GO:0000212; GO:0000281; GO:0003824; GO:0004197; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006508; GO:0006915; GO:0008234; GO:0040001; GO:0045143; GO:0045842; GO:0045875; GO:0051307; GO:0072686"
"3079",3079,"Cluster_589","Porites_evermani_scaffold_215:287759-288759",155,-23.55,2,12,597,618,10,"100.00%","100.00%","Peve_00015066",-0.999604063448837,0.0179152242682217,0.782669382293497,"P42674","Blastula protease 10 (EC 3.4.24.-)","Paracentrotus lividus (Common sea urchin)","proteolysis [GO:0006508]","GO:0004222; GO:0005615; GO:0005938; GO:0006508; GO:0008270; GO:0048471"
"3116",3116,"Cluster_589","Porites_evermani_scaffold_2822:59690-60690",160,-21.67,2,21,304,325,19,"68.42%","78.95%","Peve_00021093",-0.999211152128301,0.025288338918848,0.871601074988914,"P98133","Fibrillin-1 (MP340) [Cleaved into: Asprosin]","Bos taurus (Bovine)","activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; protein kinase A signaling [GO:0010737]","GO:0001527; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005615; GO:0006006; GO:0008201; GO:0009653; GO:0010737; GO:0031012; GO:0034199; GO:0042593"
"3166",3166,"Cluster_589","Porites_evermani_scaffold_391:48688-49688",156,-21.84,2,18,536,558,17,"76.47%","82.35%","Peve_00028238",-0.999566973841129,0.0187356109725696,0.784805430107369,"P28575","Actin-binding protein IPP (Intracisternal A particle-promoted polypeptide) (IPP) (Murine IAP-promoted placenta-expressed protein) (Protein MIPP)","Mus musculus (Mouse)","","GO:0003779; GO:0005737; GO:0005856"
"3179",3179,"Cluster_589","Porites_evermani_scaffold_4137:27104-27464",162,-23.25,2,21,60,80,19,"73.68%","84.21%","Peve_00029556",-0.997545167599482,0.0446164413451834,0.928064198164883,NA,NA,NA,NA,NA
"3184",3184,"Cluster_589","Porites_evermani_scaffold_4358:15326-16326",156,-20.29,2,19,914,934,17,"76.47%","82.35%","Peve_00030695",0.99896776402964,0.0289282378876426,0.903929377050813,"Q9IA76","60S ribosomal protein L31","Paralichthys olivaceus (Bastard halibut) (Hippoglossus olivaceus)","translation [GO:0006412]","GO:0003735; GO:0005737; GO:0005840; GO:0006412; GO:1990904"
"3205",3205,"Cluster_589","Porites_evermani_scaffold_505:47204-48204",152,-21.27,2,20,103,127,22,"68.18%","77.27%","Peve_00033813",-0.999435010130582,0.0214010903728724,0.824328633796369,"Q07076","Annexin A7 (Annexin VII) (Annexin-7) (Synexin)","Mus musculus (Mouse)","autophagy [GO:0006914]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; establishment of localization in cell [GO:0051649]; glial cell proliferation [GO:0014009]; hemostasis [GO:0007599]; insulin secretion [GO:0030073]; ion channel modulating, G protein-coupled receptor signaling pathway [GO:0099105]; ligand-gated ion channel signaling pathway [GO:1990806]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; positive regulation of insulin secretion [GO:0032024]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]","GO:0005178; GO:0005509; GO:0005544; GO:0005634; GO:0005635; GO:0005737; GO:0005789; GO:0005829; GO:0005886; GO:0006874; GO:0006914; GO:0007207; GO:0007599; GO:0008360; GO:0009651; GO:0009992; GO:0010629; GO:0014009; GO:0014070; GO:0030073; GO:0031982; GO:0032024; GO:0042584; GO:0045202; GO:0048306; GO:0051592; GO:0051649; GO:0061025; GO:0062023; GO:0099105; GO:1990806"
"3221",3221,"Cluster_589","Porites_evermani_scaffold_561:184403-185403",150,-20.84,2,11,718,739,9,"100.00%","100.00%","Peve_00035839",-0.999999999503679,2.00574810710951e-05,0.0131777650637095,"P59750","Merlin (Moesin-ezrin-radixin-like protein) (Neurofibromin-2) (Schwannomin)","Papio anubis (Olive baboon)","actin cytoskeleton organization [GO:0030036]; cell-cell junction organization [GO:0045216]; ectoderm development [GO:0007398]; hippocampus development [GO:0021766]; lens fiber cell differentiation [GO:0070306]; MAPK cascade [GO:0000165]; mesoderm formation [GO:0001707]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast proliferation [GO:0033687]; positive regulation of cell differentiation [GO:0045597]; positive regulation of stress fiber assembly [GO:0051496]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of hippo signaling [GO:0035330]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; regulation of stem cell proliferation [GO:0072091]; Schwann cell proliferation [GO:0014010]","GO:0000165; GO:0001707; GO:0001726; GO:0003779; GO:0005730; GO:0005769; GO:0005829; GO:0005912; GO:0006469; GO:0007398; GO:0010626; GO:0014010; GO:0021766; GO:0022408; GO:0030027; GO:0030036; GO:0030175; GO:0030864; GO:0031647; GO:0032154; GO:0033687; GO:0033689; GO:0035330; GO:0042475; GO:0042532; GO:0042981; GO:0043005; GO:0043409; GO:0044297; GO:0045177; GO:0045216; GO:0045597; GO:0048471; GO:0051496; GO:0051726; GO:0070306; GO:0072091; GO:1900180; GO:2000177"
"3250",3250,"Cluster_589","Porites_evermani_scaffold_84:328999-329999",152,-21.01,2,13,778,799,11,"90.91%","90.91%","Peve_00042524",-0.998208451660281,0.0381130974955327,0.909359886114279,NA,NA,NA,NA,NA
"3266",3266,"Cluster_589","Porites_evermani_scaffold_94:133708-134708",158,-24.6,2,16,799,822,16,"81.25%","87.50%","Peve_00044403",-0.999992423016843,0.00247824110430817,0.414802988923135,NA,NA,NA,NA,NA
"3271",3271,"Cluster_589","Porites_evermani_scaffold_961:151103-152103",151,-21.14,2,14,859,879,12,"91.67%","91.67%","Peve_00044772",-0.997856253350184,0.0416926466893275,0.909359886114279,"Q91XW8","Inactive peptidyl-prolyl cis-trans isomerase FKBP6 (Inactive PPIase FKBP6) (36 kDa FK506-binding protein) (36 kDa FKBP) (FKBP-36) (FK506-binding protein 6) (FKBP-6) (Immunophilin FKBP36)","Mus musculus (Mouse)","cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; meiotic cell cycle [GO:0051321]; piRNA processing [GO:0034587]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; RNA-mediated gene silencing [GO:0031047]; spermatogenesis [GO:0007283]","GO:0000795; GO:0005654; GO:0005737; GO:0005829; GO:0006457; GO:0007283; GO:0030154; GO:0031047; GO:0034587; GO:0042802; GO:0043046; GO:0045070; GO:0051321; GO:0051879"
"3274",3274,"Cluster_6255","Porites_evermani_scaffold_1242:18927-19927",159,-21.18,2,21,805,831,24,"66.67%","75.00%","Peve_00003999",-0.999977919419974,0.00423059214486466,0.54328949385489,NA,NA,NA,NA,NA
"3315",3315,"Cluster_6904","Porites_evermani_scaffold_1483:70481-71481",161,-23.17,2,19,934,956,18,"77.78%","83.33%","Peve_00007262",-0.997139931185431,0.048160049624566,0.945590536869992,"Q02763","Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b)","Homo sapiens (Human)","angiogenesis [GO:0001525]; cell-cell signaling [GO:0007267]; definitive hemopoiesis [GO:0060216]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; regulation of endothelial cell apoptotic process [GO:2000351]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]","GO:0001525; GO:0001934; GO:0001935; GO:0001938; GO:0002040; GO:0004672; GO:0004713; GO:0004714; GO:0005524; GO:0005576; GO:0005737; GO:0005886; GO:0005902; GO:0005911; GO:0005925; GO:0007165; GO:0007169; GO:0007267; GO:0007507; GO:0009925; GO:0009986; GO:0010595; GO:0014068; GO:0016323; GO:0016324; GO:0016525; GO:0018108; GO:0032878; GO:0033674; GO:0034446; GO:0034451; GO:0038023; GO:0042802; GO:0043066; GO:0043114; GO:0043235; GO:0043410; GO:0043552; GO:0045121; GO:0045766; GO:0046777; GO:0048014; GO:0050728; GO:0051894; GO:0051897; GO:0060216; GO:0060347; GO:0070374; GO:0072012; GO:1902533; GO:2000251; GO:2000351; GO:2000352"
"3323",3323,"Cluster_6904","Porites_evermani_scaffold_1781:37927-38927",149,-20.54,2,18,961,982,16,"68.75%","75.00%","Peve_00010915",-0.999463001694963,0.0208641652974758,0.817190070029867,"Q6AZS2","Polycomb protein eed-B (Xeed-B) (psXEED)","Xenopus laevis (African clawed frog)","chromatin organization [GO:0006325]","GO:0006325; GO:0035098"
"3326",3326,"Cluster_6904","Porites_evermani_scaffold_1805:77289-78289",152,-20.13,2,15,300,320,13,"84.62%","92.31%","Peve_00011228",-0.997022666930234,0.0491379058163316,0.94992237160644,"Q6GPE5","Protein fem-1 homolog B (FEM1b) (FEM1-beta)","Xenopus laevis (African clawed frog)","apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627]","GO:0005634; GO:0005737; GO:0006915; GO:0016567; GO:0031462; GO:0043161; GO:0140627; GO:1990756; GO:2000001"
"3376",3376,"Cluster_6904","Porites_evermani_scaffold_288:292124-293124",155,-20.16,2,18,692,712,16,"81.25%","81.25%","Peve_00021519",-0.999968700996602,0.00503687888605023,0.551398425649056,NA,NA,NA,NA,NA
"3378",3378,"Cluster_6904","Porites_evermani_scaffold_2897:33535-33964",162,-21.14,2,15,17,38,13,"92.31%","92.31%","Peve_00021626",-0.998711375947948,0.0323224956188328,0.909244498015575,"Q2VJ60","E3 ubiquitin-protein ligase RNF19A (EC 2.3.2.31) (Double ring-finger protein) (Dorfin) (RING finger protein 19A)","Sus scrofa (Pig)","positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0000209; GO:0005737; GO:0005815; GO:0006511; GO:0016020; GO:0031624; GO:0032436; GO:0046872; GO:0061630; GO:0098686; GO:0098794; GO:0098978; GO:0099576"
"3434",3434,"Cluster_6904","Porites_evermani_scaffold_61:88103-89103",156,-21.91,2,20,960,982,20,"75.00%","80.00%","Peve_00037342",-0.998706114075126,0.0323884342508462,0.909244498015575,NA,NA,NA,NA,NA
"3436",3436,"Cluster_6904","Porites_evermani_scaffold_623:190876-191876",155,-21.07,2,19,756,777,18,"77.78%","83.33%","Peve_00037704",-0.998219553343417,0.0379947911463899,0.909359886114279,NA,NA,NA,NA,NA
"3466",3466,"Cluster_6904","Porites_evermani_scaffold_844:40536-41536",161,-21.69,2,19,672,694,18,"72.22%","88.89%","Peve_00042648",-0.999469703920853,0.0207335430475651,0.81520158559417,"A5PMX1","Zinc transporter 7 (ZnT-7) (Solute carrier family 30 member 7)","Danio rerio (Zebrafish) (Brachydanio rerio)","cellular zinc ion homeostasis [GO:0006882]; metal ion transport [GO:0030001]; zinc ion import into Golgi lumen [GO:1904257]; zinc ion transport [GO:0006829]","GO:0005385; GO:0005794; GO:0006829; GO:0006882; GO:0016020; GO:0030001; GO:0031410; GO:0046873; GO:1904257"
"3523",3523,"Cluster_6905","Porites_evermani_scaffold_2931:44010-45010",157,-26.54,2,20,406,426,18,"77.78%","77.78%","Peve_00021945",-0.999971374472759,0.00481695849265739,0.551398425649056,NA,NA,NA,NA,NA
"3567",3567,"Cluster_6905","Porites_evermani_scaffold_834:34697-35697",164,-26.63,2,17,809,830,15,"86.67%","86.67%","Peve_00042462",-0.999901669120146,0.00892778333881972,0.587136688814728,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"3593",3593,"Cluster_6906","Porites_evermani_scaffold_1457:27387-28387",162,-26.98,2,20,746,772,23,"73.91%","73.91%","Peve_00006922",0.999971311671877,0.00482223952987791,0.551398425649056,"Q9NTG1","Polycystin family receptor for egg jelly (PKD and REJ homolog) (Polycystic kidney disease and receptor for egg jelly-related protein)","Homo sapiens (Human)","acrosome reaction [GO:0007340]; detection of mechanical stimulus [GO:0050982]","GO:0005262; GO:0005509; GO:0007340; GO:0016020; GO:0050982"
"3736",3736,"Cluster_6906","Porites_evermani_scaffold_84:522681-523681",154,-20.14,2,16,501,523,15,"80.00%","86.67%","Peve_00042534",-0.999911200410267,0.00848406162211117,0.573710369894872,NA,NA,NA,NA,NA
"3742",3742,"Cluster_6906","Porites_evermani_scaffold_899:125706-126706",153,-21.26,2,19,666,690,20,"65.00%","80.00%","Peve_00043593",-0.997871906088051,0.0415401024981488,0.909359886114279,NA,NA,NA,NA,NA
"3748",3748,"Cluster_6914","Porites_evermani_scaffold_100:36597-37597",162,-22.04,2,17,22,41,15,"86.67%","93.33%","Peve_00000232",-0.99998857382088,0.00304330898553907,0.474160259106401,NA,NA,NA,NA,NA
"3791",3791,"Cluster_6914","Porites_evermani_scaffold_3145:48457-49457",150,-21.36,2,20,553,569,18,"72.22%","77.78%","Peve_00023691",0.998994743896135,0.0285476174462189,0.903929377050813,"P36836","Solute carrier family 15 member 1 (Intestinal H(+)/peptide cotransporter) (Oligopeptide transporter, small intestine isoform) (Peptide transporter 1)","Oryctolagus cuniculus (Rabbit)","dipeptide import across plasma membrane [GO:0140206]; protein transport [GO:0015031]; tripeptide import across plasma membrane [GO:0140207]","GO:0015031; GO:0015333; GO:0016020; GO:0016324; GO:0042937; GO:0071916; GO:0140206; GO:0140207"
"3828",3828,"Cluster_6914","Porites_evermani_scaffold_822:154124-155124",146,-20.01,2,20,25,48,21,"61.90%","71.43%","Peve_00042248",-0.99760688237923,0.0440518133990858,0.923915229231156,"Q96AY4","Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio)","Homo sapiens (Human)","cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346]","GO:0000922; GO:0005737; GO:0005815; GO:0007049; GO:0007346; GO:0019900; GO:0030496; GO:0051301"
"3847",3847,"Cluster_7053","Porites_evermani_scaffold_1531:12971-13971",154,-22.29,2,21,150,177,25,"64.00%","76.00%","Peve_00007907",0.998593755293202,0.0337657560132954,0.909359886114279,NA,NA,NA,NA,NA
"3855",3855,"Cluster_7053","Porites_evermani_scaffold_2069:39181-40181",159,-20.72,2,21,630,654,22,"72.73%","72.73%","Peve_00014221",-0.999884527015562,0.00967474429161349,0.611343259425713,NA,NA,NA,NA,NA
"3883",3883,"Cluster_7053","Porites_evermani_scaffold_908:74556-75556",144,-20.36,2,18,376,400,19,"57.89%","78.95%","Peve_00043872",-0.999374953775323,0.0225099128069867,0.838257076229427,"P35555","Fibrillin-1 [Cleaved into: Asprosin]","Homo sapiens (Human)","activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; positive regulation of appetite [GO:0032100]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]","GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0009653; GO:0010737; GO:0030023; GO:0031012; GO:0032100; GO:0033627; GO:0034199; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0062023; GO:0071560; GO:1990314; GO:2001205"
"3947",3947,"Cluster_7855","Porites_evermani_scaffold_348:261313-262313",175,-22.08,2,21,824,847,21,"76.19%","90.48%","Peve_00025803",-0.998338998790929,0.0366978166950436,0.909359886114279,"Q6Q0C0","E3 ubiquitin-protein ligase TRAF7 (EC 2.3.2.27) (RING finger and WD repeat-containing protein 1) (RING finger protein 119) (RING-type E3 ubiquitin transferase TRAF7) (TNF receptor-associated factor 7)","Homo sapiens (Human)","apoptotic process [GO:0006915]; Notch signaling pathway [GO:0007219]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of MAPK cascade [GO:0043410]; protein ubiquitination [GO:0016567]; regulation of ERK1 and ERK2 cascade [GO:0070372]; ribosomal large subunit assembly [GO:0000027]","GO:0000027; GO:0000151; GO:0004842; GO:0005730; GO:0005886; GO:0006915; GO:0007219; GO:0008270; GO:0016567; GO:0031410; GO:0043231; GO:0043410; GO:0070372; GO:2001235"
"3971",3971,"Cluster_796","Porites_evermani_scaffold_1031:98941-99941",158,-21.02,2,20,915,937,19,"73.68%","78.95%","Peve_00000718",0.998052856721296,0.0397342088666192,0.909359886114279,"Q8IWZ3","Ankyrin repeat and KH domain-containing protein 1 (HIV-1 Vpr-binding ankyrin repeat protein) (Multiple ankyrin repeats single KH domain) (hMASK)","Homo sapiens (Human)","innate immune response [GO:0045087]","GO:0003723; GO:0005737; GO:0045087"
"4023",4023,"Cluster_796","Porites_evermani_scaffold_1928:15476-16476",140,-21.31,2,9,107,128,7,"100.00%","100.00%","Peve_00012591",0.999716689332843,0.01515433341596,0.745846175256963,"Q8INF0","Soluble guanylate cyclase 88E (EC 4.6.1.2)","Drosophila melanogaster (Fruit fly)","cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; response to hypoxia [GO:0001666]; response to oxygen levels [GO:0070482]; response to reactive oxygen species [GO:0000302]","GO:0000302; GO:0001666; GO:0003924; GO:0004383; GO:0005525; GO:0008074; GO:0019825; GO:0019826; GO:0019899; GO:0019934; GO:0020037; GO:0038060; GO:0042803; GO:0046872; GO:0046982; GO:0070025; GO:0070026; GO:0070482"
"4075",4075,"Cluster_796","Porites_evermani_scaffold_3592:21177-22177",154,-22.4,2,21,754,774,19,"73.68%","73.68%","Peve_00026480",0.997091645416707,0.0485650802695336,0.947582413903802,NA,NA,NA,NA,NA
"4081",4081,"Cluster_796","Porites_evermani_scaffold_390:230931-231931",153,-22.06,2,19,523,546,19,"68.42%","78.95%","Peve_00028200",-0.999345888781346,0.0230273835955368,0.844611056711255,NA,NA,NA,NA,NA
"4118",4118,"Cluster_796","Porites_evermani_scaffold_5490:649-1649",140,-22.48,2,9,181,202,7,"100.00%","100.00%","Peve_00035430",0.999102854913975,0.0269686331853911,0.890748160714267,"Q9NRM2","Zinc finger protein 277 (Nuclear receptor-interacting factor 4)","Homo sapiens (Human)","cellular response to hydrogen peroxide [GO:0070301]; regulation of cellular senescence [GO:2000772]","GO:0000978; GO:0005634; GO:0046872; GO:0070301; GO:2000772"
"4134",4134,"Cluster_796","Porites_evermani_scaffold_6:694875-695875",151,-20.54,2,21,403,428,23,"60.87%","73.91%","Peve_00036964",0.997077513398696,0.0486829862370013,0.94805481250488,"Q80TN7","Neuron navigator 3 (Pore membrane and/or filament-interacting-like protein 1)","Mus musculus (Mouse)","negative regulation of cell migration [GO:0030336]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]","GO:0005524; GO:0005634; GO:0005635; GO:0005640; GO:0007026; GO:0007399; GO:0008017; GO:0016887; GO:0022008; GO:0030336; GO:0031116; GO:0032703; GO:1990752"
"4175",4175,"Cluster_8634","Porites_evermani_scaffold_1548:71038-72038",167,-21.28,2,18,774,794,16,"87.50%","93.75%","Peve_00008072",0.999978963950975,0.00412931457669044,0.54328949385489,NA,NA,NA,NA,NA
"4187",4187,"Cluster_8634","Porites_evermani_scaffold_25:786971-787971",168,-23.21,2,18,785,809,19,"84.21%","84.21%","Peve_00018391",0.998840656587306,0.030657951802389,0.903929377050813,"Q9CQI7","U2 small nuclear ribonucleoprotein B'' (U2 snRNP B'')","Mus musculus (Mouse)","mRNA splicing, via spliceosome [GO:0000398]","GO:0000398; GO:0001650; GO:0005634; GO:0005681; GO:0005685; GO:0005686; GO:0016607; GO:0030532; GO:0030619; GO:0036464; GO:0070990; GO:0071005; GO:0071007; GO:0071013"
"4192",4192,"Cluster_8634","Porites_evermani_scaffold_2:956682-957682",167,-21.89,2,21,266,289,21,"76.19%","80.95%","Peve_00013384",0.999374263578392,0.0225223387727307,0.83828463858421,NA,NA,NA,NA,NA
"4201",4201,"Cluster_8634","Porites_evermani_scaffold_349:212165-212859",167,-21.25,2,21,466,488,20,"75.00%","85.00%","Peve_00025850",0.999912402411178,0.00842644454811202,0.573710369894872,"O54990","Prominin-1 (Antigen AC133 homolog) (Prominin-like protein 1) (CD antigen CD133)","Mus musculus (Mouse)","camera-type eye photoreceptor cell differentiation [GO:0060219]; glomerular parietal epithelial cell differentiation [GO:0072139]; photoreceptor cell maintenance [GO:0045494]; podocyte differentiation [GO:0072112]; positive regulation of nephron tubule epithelial cell differentiation [GO:2000768]; retina layer formation [GO:0010842]; retina morphogenesis in camera-type eye [GO:0060042]","GO:0001750; GO:0005615; GO:0005783; GO:0005793; GO:0005886; GO:0005902; GO:0005903; GO:0005929; GO:0009986; GO:0010842; GO:0015485; GO:0016324; GO:0031528; GO:0032420; GO:0042622; GO:0042805; GO:0042995; GO:0045296; GO:0045494; GO:0060042; GO:0060219; GO:0070062; GO:0071914; GO:0072112; GO:0072139; GO:2000768"
"4223",4223,"Cluster_8634","Porites_evermani_scaffold_672:115782-116782",171,-23.07,2,21,935,957,20,"80.00%","85.00%","Peve_00038875",0.99912526170216,0.0266296742754265,0.887027605960946,"Q9CSN1","SNW domain-containing protein 1 (Nuclear protein SkiP) (Ski-interacting protein)","Mus musculus (Mouse)","cellular response to retinoic acid [GO:0071300]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of vitamin D receptor signaling pathway [GO:0070564]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinoic acid receptor signaling pathway [GO:0048384]; skeletal muscle cell differentiation [GO:0035914]","GO:0000122; GO:0000398; GO:0000785; GO:0003713; GO:0003714; GO:0005112; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0008024; GO:0016363; GO:0016604; GO:0016607; GO:0016922; GO:0019899; GO:0030511; GO:0035914; GO:0042771; GO:0042809; GO:0042974; GO:0043923; GO:0045892; GO:0045944; GO:0046332; GO:0048026; GO:0048384; GO:0048385; GO:0050681; GO:0050769; GO:0051571; GO:0070562; GO:0070564; GO:0071007; GO:0071013; GO:0071141; GO:0071300"
"4228",4228,"Cluster_8634","Porites_evermani_scaffold_77:256641-257641",169,-20.66,2,18,804,825,16,"87.50%","87.50%","Peve_00041049",0.998453622764511,0.0354086057088602,0.909359886114279,"Q9Y5X5","Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor)","Homo sapiens (Human)","detection of abiotic stimulus [GO:0009582]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of adenylate cyclase activity [GO:0045761]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of MAPK cascade [GO:0043408]","GO:0004930; GO:0005886; GO:0007186; GO:0008188; GO:0009582; GO:0015629; GO:0031628; GO:0042277; GO:0043408; GO:0045761; GO:2000479"
"4278",4278,"Cluster_8884","Porites_evermani_scaffold_3530:16210-17210",153,-20.15,2,20,649,673,22,"68.18%","77.27%","Peve_00026145",0.997253647308052,0.047192471195222,0.941791888778827,NA,NA,NA,NA,NA
"4284",4284,"Cluster_8884","Porites_evermani_scaffold_397:4173-5173",166,-20.49,2,19,605,625,17,"76.47%","88.24%","Peve_00028555",-0.997387077455361,0.0460312744260222,0.935169468683523,NA,NA,NA,NA,NA
"4347",4347,"Cluster_8887","Porites_evermani_scaffold_215:251168-252168",153,-24.97,2,20,572,594,20,"70.00%","80.00%","Peve_00015062",-0.99991446441509,0.00832667533146618,0.573710369894872,"P55115","Zinc metalloproteinase nas-15 (EC 3.4.24.-) (Nematode astacin 15)","Caenorhabditis elegans","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270"
"4382",4382,"Cluster_8887","Porites_evermani_scaffold_479:204727-205727",162,-23.29,2,20,214,235,19,"73.68%","84.21%","Peve_00032682",-0.99825928797896,0.0375683052200161,0.909359886114279,"O15381","Nuclear valosin-containing protein-like (NVLp) (Nuclear VCP-like protein)","Homo sapiens (Human)","positive regulation of protein binding [GO:0032092]; positive regulation of telomerase activity [GO:0051973]; regulation of protein localization to nucleolus [GO:1904749]; ribosomal large subunit biogenesis [GO:0042273]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]","GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006364; GO:0016020; GO:0016887; GO:0032092; GO:0042254; GO:0042273; GO:0051973; GO:1904749; GO:1990275"
"4397",4397,"Cluster_8887","Porites_evermani_scaffold_921:19047-20047",155,-23.35,2,12,486,506,10,"100.00%","100.00%","Peve_00044134",-0.999836960200136,0.0114960286738644,0.661528833813137,"Q6ITT3","Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C (EC 2.4.1.145) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVc) (GnT-IVc) (N-acetylglucosaminyltransferase IVc) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVc)","Sus scrofa (Pig)","protein N-linked glycosylation [GO:0006487]","GO:0000139; GO:0006487; GO:0008375; GO:0008454; GO:0046872"
"4458",4458,"Cluster_8888","Porites_evermani_scaffold_667:95488-96488",160,-20.8,2,19,518,541,20,"75.00%","85.00%","Peve_00038750",-0.999995310085062,0.00194974481237643,0.362847063101065,"Q9WVK8","Cholesterol 24-hydroxylase (CH24H) (EC 1.14.14.25) (Cholesterol 24-monooxygenase) (Cholesterol 24S-hydroxylase) (Cytochrome P450 46A1)","Mus musculus (Mouse)","cholesterol catabolic process [GO:0006707]; progesterone metabolic process [GO:0042448]; protein localization to membrane raft [GO:1903044]; regulation of long-term synaptic potentiation [GO:1900271]; xenobiotic metabolic process [GO:0006805]","GO:0005506; GO:0005789; GO:0006707; GO:0006805; GO:0008395; GO:0020037; GO:0030425; GO:0033781; GO:0042448; GO:0062184; GO:0098793; GO:0098794; GO:1900271; GO:1903044"
"4462",4462,"Cluster_8888","Porites_evermani_scaffold_743:39942-40942",154,-22.08,2,20,501,518,18,"77.78%","83.33%","Peve_00040567",-0.999850946843342,0.0109918578760632,0.647820986329688,NA,NA,NA,NA,NA
"4492",4492,"Cluster_8988","Porites_evermani_scaffold_1844:27707-28707",154,-21.75,2,20,650,673,20,"60.00%","85.00%","Peve_00011634",0.99725770910753,0.0471575439540669,0.941529418834028,NA,NA,NA,NA,NA
"4499",4499,"Cluster_8988","Porites_evermani_scaffold_1954:63091-64091",163,-20.13,2,21,344,366,20,"70.00%","85.00%","Peve_00012869",-0.997041894647782,0.0489789031235421,0.949444666171571,NA,NA,NA,NA,NA
"4517",4517,"Cluster_8988","Porites_evermani_scaffold_251:283042-284042",168,-21.61,2,21,238,259,19,"73.68%","84.21%","Peve_00018542",0.999797047339721,0.0128262541271408,0.695994506963882,NA,NA,NA,NA,NA
"4537",4537,"Cluster_8988","Porites_evermani_scaffold_423:155022-156022",163,-20.03,2,20,475,496,18,"61.11%","94.44%","Peve_00030038",-0.999550307649831,0.0190927790579351,0.790551218379749,NA,NA,NA,NA,NA
"4542",4542,"Cluster_8988","Porites_evermani_scaffold_4938:1080-2080",169,-22.25,2,18,618,639,16,"81.25%","93.75%","Peve_00033284",0.998215951089572,0.0380332192580478,0.909359886114279,NA,NA,NA,NA,NA
"4570",4570,"Cluster_9149","Porites_evermani_scaffold_104:15386-16386",151,-21.47,2,21,27,49,20,"60.00%","80.00%","Peve_00000825",0.999999240744832,0.000784492916512268,0.239778920002343,"Q8IW35","Centrosomal protein of 97 kDa (Cep97) (Leucine-rich repeat and IQ domain-containing protein 2)","Homo sapiens (Human)","cell projection organization [GO:0030030]; negative regulation of cilium assembly [GO:1902018]; regulation of mitotic spindle assembly [GO:1901673]","GO:0005516; GO:0005813; GO:0005814; GO:0005829; GO:0030030; GO:0032991; GO:1901673; GO:1902018"
"4588",4588,"Cluster_9149","Porites_evermani_scaffold_1132:33092-34092",150,-21.69,2,11,318,339,9,"100.00%","100.00%","Peve_00002320",-0.998696026270262,0.0325144749625038,0.909359886114279,"Q8NDA2","Hemicentin-2","Homo sapiens (Human)","axon guidance [GO:0007411]; cell adhesion [GO:0007155]","GO:0005509; GO:0005615; GO:0007155; GO:0007411; GO:0031012; GO:0032154; GO:0062023"
"4592",4592,"Cluster_9149","Porites_evermani_scaffold_1193:47035-48035",156,-23.76,2,18,827,849,17,"76.47%","82.35%","Peve_00003234",0.999997860909741,0.0013167694840572,0.317099882619675,"Q01528","Hemagglutinin/amebocyte aggregation factor (18K-LAF)","Limulus polyphemus (Atlantic horseshoe crab)","","GO:0005576"
"4600",4600,"Cluster_9149","Porites_evermani_scaffold_1281:60683-61683",161,-26.99,2,21,656,677,20,"75.00%","85.00%","Peve_00004521",-0.997395120221082,0.0459603451867603,0.934642337937236,NA,NA,NA,NA,NA
"4601",4601,"Cluster_9149","Porites_evermani_scaffold_1281:60956-61956",161,-26.99,2,21,383,404,20,"75.00%","85.00%","Peve_00004512",-0.999408825461995,0.021891442456906,0.830089015811238,"Q91ZA8","Notch-regulated ankyrin repeat-containing protein","Mus musculus (Mouse)","blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; branching involved in blood vessel morphogenesis [GO:0001569]; endothelial cell proliferation [GO:0001935]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of Notch signaling pathway involved in somitogenesis [GO:1902367]; negative regulation of T cell differentiation [GO:0045581]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of cell-cell adhesion [GO:0022407]; somite rostral/caudal axis specification [GO:0032525]; sprouting angiogenesis [GO:0002040]; T cell differentiation [GO:0030217]; vascular endothelial cell proliferation [GO:0101023]","GO:0000122; GO:0001569; GO:0001935; GO:0001938; GO:0002040; GO:0002043; GO:0007219; GO:0022407; GO:0030217; GO:0032525; GO:0045581; GO:0045746; GO:0090263; GO:0101023; GO:1902367; GO:1905564"
"4681",4681,"Cluster_9149","Porites_evermani_scaffold_1898:68217-69217",150,-21.59,2,18,863,882,16,"75.00%","81.25%","Peve_00012208",-0.999327894094028,0.0233420128583658,0.848872825778705,"Q9NZJ4","Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)","Homo sapiens (Human)","negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]","GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0042802; GO:0051087; GO:0070628; GO:0070852; GO:0090084"
"4683",4683,"Cluster_9149","Porites_evermani_scaffold_190:283919-284296",146,-20.99,2,12,30,52,11,"90.91%","90.91%","Peve_00012302",-0.999865571060301,0.0104386989464617,0.634381120973208,NA,NA,NA,NA,NA
"4685",4685,"Cluster_9149","Porites_evermani_scaffold_191:250133-251133",145,-20.88,2,20,505,531,23,"65.22%","69.57%","Peve_00012404",0.999998523194906,0.00109409936293585,0.275560959970807,NA,NA,NA,NA,NA
"4702",4702,"Cluster_9149","Porites_evermani_scaffold_209:134407-135407",146,-20.35,2,20,308,330,19,"63.16%","73.68%","Peve_00014451",1,0,0,NA,NA,NA,NA,NA
"4729",4729,"Cluster_9149","Porites_evermani_scaffold_2326:23017-24017",171,-24.95,2,21,576,598,20,"80.00%","85.00%","Peve_00016786",1,0,0,NA,NA,NA,NA,NA
"4732",4732,"Cluster_9149","Porites_evermani_scaffold_233:235186-236186",154,-21.98,2,20,735,762,24,"66.67%","70.83%","Peve_00016830",0.997175508499252,0.0478594310724678,0.945152902495684,"O94923","D-glucuronyl C5-epimerase (EC 5.1.3.17) (Heparan sulfate C5-epimerase) (Hsepi) (Heparin/heparan sulfate:glucuronic acid C5-epimerase) (Heparosan-N-sulfate-glucuronate 5-epimerase)","Homo sapiens (Human)","heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin biosynthetic process [GO:0030210]","GO:0000139; GO:0005509; GO:0005794; GO:0015012; GO:0016857; GO:0030210; GO:0042803; GO:0047464"
"4741",4741,"Cluster_9149","Porites_evermani_scaffold_243:321051-322051",145,-20.9,2,19,128,146,17,"76.47%","76.47%","Peve_00017781",0.99695799908616,0.0496689462152669,0.952044988713482,NA,NA,NA,NA,NA
"4775",4775,"Cluster_9149","Porites_evermani_scaffold_2747:3260-4260",159,-24.41,2,21,944,966,20,"70.00%","80.00%","Peve_00020492",-0.999191159467906,0.0256068319396386,0.875231632834556,NA,NA,NA,NA,NA
"4800",4800,"Cluster_9149","Porites_evermani_scaffold_302:234649-235649",160,-24.25,2,19,196,216,17,"76.47%","88.24%","Peve_00022773",1,0,0,"Q8VCK5","Kelch-like protein 20 (Kelch-like ECT2-interacting protein)","Mus musculus (Mouse)","Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]","GO:0003779; GO:0004842; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0030424; GO:0030425; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390"
"4801",4801,"Cluster_9149","Porites_evermani_scaffold_3025:30316-31316",159,-21.13,2,21,739,764,23,"69.57%","73.91%","Peve_00022813",-0.998924716861794,0.0295253777049622,0.903929377050813,NA,NA,NA,NA,NA
"4812",4812,"Cluster_9149","Porites_evermani_scaffold_3167:4216-5216",147,-20.45,2,12,916,937,10,"80.00%","100.00%","Peve_00023808",-0.998460036492421,0.0353350804494513,0.909359886114279,NA,NA,NA,NA,NA
"4825",4825,"Cluster_9149","Porites_evermani_scaffold_3344:45501-46501",156,-22.67,2,21,885,906,19,"63.16%","78.95%","Peve_00024938",1,0,0,"A2AJ88","Patatin-like phospholipase domain-containing protein 7 (EC 3.1.1.-) (EC 3.1.1.5) (Neuropathy target esterase-related esterase) (NRE) (NTE-related esterase)","Mus musculus (Mouse)","phosphatidylcholine catabolic process [GO:0034638]","GO:0004622; GO:0005783; GO:0005789; GO:0005811; GO:0034638; GO:0102545"
"4841",4841,"Cluster_9149","Porites_evermani_scaffold_361:170652-171652",143,-20.34,2,14,140,160,12,"75.00%","91.67%","Peve_00026617",1,0,0,NA,NA,NA,NA,NA
"4842",4842,"Cluster_9149","Porites_evermani_scaffold_361:170652-171652",143,-20.34,2,14,456,476,12,"75.00%","91.67%","Peve_00026617",1,0,0,NA,NA,NA,NA,NA
"4868",4868,"Cluster_9149","Porites_evermani_scaffold_4017:25046-26046",145,-20.4,2,20,426,454,25,"64.00%","68.00%","Peve_00028917",1,0,0,"Q6DG99","BTB/POZ domain-containing protein KCTD6","Danio rerio (Zebrafish) (Brachydanio rerio)","protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]","GO:0016567; GO:0051260"
"4948",4948,"Cluster_9149","Porites_evermani_scaffold_596:13069-14069",160,-23.52,2,21,813,834,19,"63.16%","84.21%","Peve_00036859",-0.996982195269473,0.0494709177037855,0.950846381223965,"Q9CZR2","N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylaspartylglutamate peptidase II) (NAAG-peptidase II) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II)","Mus musculus (Mouse)","neurotransmitter catabolic process [GO:0042135]; proteolysis [GO:0006508]","GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0008233; GO:0016020; GO:0016805; GO:0042135; GO:0046872; GO:0050129"
"4970",4970,"Cluster_9149","Porites_evermani_scaffold_6636:1874-2874",152,-25.61,2,17,294,313,15,"86.67%","86.67%","Peve_00038692",1,0,0,NA,NA,NA,NA,NA
"4973",4973,"Cluster_9149","Porites_evermani_scaffold_67:473630-474630",147,-22.28,2,21,694,719,23,"60.87%","69.57%","Peve_00038822",-0.997148176496447,0.0480905459806356,0.945590536869992,"Q8VHI5","Vitrin (Akhirin)","Mus musculus (Mouse)","extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811]; spinal cord development [GO:0021510]","GO:0005539; GO:0005576; GO:0005614; GO:0010811; GO:0021510; GO:0030198; GO:0031012; GO:0062023"
"4987",4987,"Cluster_9149","Porites_evermani_scaffold_73:327526-328526",147,-22.85,2,12,920,941,10,"80.00%","100.00%","Peve_00040250",1,9.48637384723993e-09,6.86838308108347e-06,NA,NA,NA,NA,NA
"5008",5008,"Cluster_9149","Porites_evermani_scaffold_84:338535-339535",160,-21,2,21,593,614,19,"68.42%","78.95%","Peve_00042525",-0.999972017506869,0.00476254767800266,0.551398425649056,"Q5ZI57","Trafficking protein particle complex subunit 3","Gallus gallus (Chicken)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]","GO:0005783; GO:0005829; GO:0006888; GO:0006891; GO:0030008; GO:0033106"
"5034",5034,"Cluster_9149","Porites_evermani_scaffold_98:109116-110116",164,-29.67,2,17,266,287,15,"80.00%","93.33%","Peve_00045047",-0.999996728114699,0.00162852441741808,0.362847063101065,NA,NA,NA,NA,NA
"5042",5042,"Cluster_9983","Porites_evermani_scaffold_23:429510-430510",159,-22.76,2,20,799,816,18,"77.78%","83.33%","Peve_00016482",-0.999812133109256,0.0123403376847463,0.684071498890361,"E9Q3T6","PR domain zinc finger protein 14 (EC 2.1.1.-) (PR domain-containing protein 14)","Mus musculus (Mouse)","cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; epigenetic regulation of gene expression [GO:0040029]; fertilization [GO:0009566]; fibroblast growth factor receptor signaling pathway [GO:0008543]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; histone H3-R26 methylation [GO:0034972]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome [GO:0060817]; inner cell mass cell fate commitment [GO:0001827]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of DNA methylation [GO:0044030]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; stem cell population maintenance [GO:0019827]","GO:0000122; GO:0000902; GO:0000977; GO:0001227; GO:0001708; GO:0001827; GO:0003723; GO:0005634; GO:0005654; GO:0006357; GO:0007281; GO:0007566; GO:0008168; GO:0008543; GO:0009566; GO:0010468; GO:0019827; GO:0030718; GO:0031490; GO:0034972; GO:0040029; GO:0040037; GO:0044030; GO:0046872; GO:0048873; GO:0060817; GO:1902093; GO:1902459"
